细胞株Cell Lines 83及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV83
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID NCI-H1498
AC CVCL_A497
SY H1498; H-1498
DR Cosmic; 930485
RX PubMed=8806092;
RX PubMed=11030152;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C2923; Bronchioloalveolar carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1512
AC CVCL_A498
SY H1512; H-1512
RX PubMed=8806092;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1514
AC CVCL_4363
SY H1514; H-1514
DR ATCC; CRL-5873
DR BioSample; SAMN03152020
DR BioSample; SAMN03472582
DR Cosmic; 877223
DR Cosmic; 877380
DR Cosmic; 980949
DR Cosmic; 1021876
DR Cosmic; 1032419
DR GEO; GSM794317
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=20143388;
RX PubMed=20679594;
WW http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388).
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-5873; true.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; PubMed=20679594
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 12 (ATCC)
ST D13S317: 11,12 (PubMed=20679594)
ST D16S539: 11
ST D5S818: 11
ST D7S820: 9,12
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 17,21,22 (ATCC)
ST vWA: 17,21 (PubMed=20679594)
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2641 ! NCI-BL1514
SX Male
CA Cancer cell line
//
ID NCI-H1522
AC CVCL_1474
SY H1522; H-1522
DR CLO; CLO_0007999
DR ATCC; CRL-5874
DR BioSample; SAMN03472583
DR ChEMBL-Cells; CHEMBL3308877
DR ChEMBL-Targets; CHEMBL2366178
DR Cosmic; 688004
DR Cosmic; 877224
DR Cosmic; 877381
DR Cosmic; 908464
DR GDSC; 908464
DR GEO; GSM827534
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 11
ST D5S818: 11
ST D7S820: 9,11,12
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 17,20
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1548
AC CVCL_A499
SY H1548; H-1548
RX PubMed=8806092;
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1563
AC CVCL_1475
SY H1563; H-1563
DR CLO; CLO_0008000
DR EFO; EFO_0002255
DR ATCC; CRL-5875
DR BioSample; SAMN03473021
DR CCLE; NCIH1563_LUNG
DR ChEMBL-Cells; CHEMBL3308457
DR ChEMBL-Targets; CHEMBL1075514
DR Cosmic; 753600
DR Cosmic; 1146879
DR Cosmic-CLP; 753600
DR GDSC; 753600
DR GEO; GSM434327
DR GEO; GSM513940
DR GEO; GSM514326
DR GEO; GSM784195
DR GEO; GSM794318
DR GEO; GSM827536
DR GEO; GSM887366
DR GEO; GSM888444
DR GEO; GSM1670175
DR IGRhCellID; H1563GEO
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,14
ST D16S539: 9,13
ST D18S51: 13,17
ST D21S11: 28,30
ST D3S1358: 16,17
ST D5S818: 12,13
ST D7S820: 7,8
ST D8S1179: 13
ST FGA: 21,23
ST Penta D: 12,15
ST Penta E: 10,13
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1568
AC CVCL_1476
SY H1568; H-1568
DR CLO; CLO_0008001
DR EFO; EFO_0006660
DR ATCC; CRL-5876
DR BioSample; SAMN03471252
DR CCLE; NCIH1568_LUNG
DR Cosmic; 903594
DR Cosmic; 1146880
DR Cosmic; 1995525
DR Cosmic-CLP; 1298348
DR GDSC; 1298348
DR GEO; GSM206473
DR GEO; GSM434278
DR GEO; GSM513941
DR GEO; GSM514327
DR GEO; GSM784205
DR GEO; GSM794319
DR GEO; GSM827505
DR GEO; GSM887367
DR GEO; GSM888445
DR GEO; GSM1670176
DR IGRhCellID; H1568GEO
DR PRIDE; PXD002556
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=26361996;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 10,12
ST D18S51: 18
ST D21S11: 29
ST D3S1358: 17
ST D5S818: 9
ST D7S820: 8,9
ST D8S1179: 13,14
ST FGA: 23
ST Penta D: 11
ST Penta E: 12,13
ST TH01: 9 (ATCC; PubMed=25877200)
ST TH01: 7,9 (Cosmic-CLP)
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H157
AC CVCL_0463
SY NCl-H157; H157; H-157; NCI-157
DR BTO; BTO:0002283
DR EFO; EFO_0003118
DR MCCL; MCC:0000360
DR ATCC; CRL-5802
DR BioSample; SAMN03151855
DR BioSample; SAMN03471738
DR CCRID; 3111C0001CCC000113
DR ChEMBL-Cells; CHEMBL3307706
DR ChEMBL-Targets; CHEMBL614783
DR Cosmic; 722053
DR Cosmic; 724867
DR Cosmic; 801588
DR Cosmic; 844816
DR Cosmic; 852006
DR Cosmic; 876171
DR Cosmic; 877258
DR Cosmic; 903569
DR Cosmic; 911847
DR Cosmic; 917987
DR Cosmic; 929971
DR Cosmic; 930486
DR Cosmic; 932921
DR Cosmic; 934546
DR Cosmic; 953987
DR Cosmic; 949208
DR Cosmic; 980960
DR Cosmic; 1028954
DR Cosmic; 1032432
DR Cosmic; 1146881
DR Cosmic; 1219061
DR Cosmic; 1239910
DR Cosmic; 1320185
DR GEO; GSM6296
DR GEO; GSM253365
DR GEO; GSM434267
DR GEO; GSM784238
DR GEO; GSM794274
DR IGRhCellID; H157GEO
DR KCB; KCB 200814YJ
DR KCLB; 90157
DR PRIDE; PXD002556
RX PubMed=1563005;
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=9649128;
RX PubMed=11005564;
RX PubMed=11369051;
RX PubMed=19472407;
RX PubMed=23381221;
RX PubMed=25120651;
RX PubMed=26361996;
WW http://www.atcc.org/support/faqs/05d55/Cross-contamination%20of%20ATCC%20CRL-5802%20and%20ATCC%20CRL-5860-931.aspx
WW http://www.atcc.org/support/faqs/78ebc/Contaminating%20Line%20for%20ATCC%20CRL5802%20vs%20ATCC%20CRL5860-932.aspx
WW http://www.atcc.org/support/faqs/bb641/Misidentified%20Cell%20Lines%20ATCC%20CRL-5802%20and%20ATCC%20CRL-5860-930.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. NCI-H157 and NCI-H1264 have been shown to be identical.
CC Omics: Deep proteome analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-5802; true.
CC Discontinued: KCLB; 90157; probable.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 12,13
ST D5S818: 10,13
ST D7S820: 12
ST TH01: 7,9
ST TPOX: 6,12
ST vWA: 15
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3970 ! NCI-H1264
SX Male
CA Cancer cell line
//
ID NCI-H1570
AC CVCL_A500
SY H1570; H-1570
DR Cosmic; 722042
DR GEO; GSM794320
RX PubMed=1563005;
RX PubMed=8806092;
RX PubMed=11030152;
CC Omics: Transcriptome analysis.
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1573
AC CVCL_1478
SY H1573; H-1573
DR CLO; CLO_0008002
DR EFO; EFO_0002256
DR ATCC; CRL-5877
DR BioSample; SAMN03472584
DR CCLE; NCIH1573_LUNG
DR ChEMBL-Cells; CHEMBL3308117
DR ChEMBL-Targets; CHEMBL1075515
DR Cosmic; 687796
DR Cosmic; 877243
DR Cosmic; 877425
DR Cosmic; 903595
DR Cosmic; 908472
DR Cosmic; 1995526
DR Cosmic; 2125179
DR Cosmic-CLP; 908472
DR GDSC; 908472
DR GEO; GSM794321
DR GEO; GSM827530
DR GEO; GSM887368
DR GEO; GSM888446
DR GEO; GSM1670177
DR IGRhCellID; NCIH1573
DR KCLB; 91573
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,13
ST D16S539: 12
ST D5S818: 11,13
ST D7S820: 9,11
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1581
AC CVCL_1479
SY H1581; H-1581; NCIH1581
DR CLO; CLO_0008003
DR EFO; EFO_0002257
DR ATCC; CRL-5878
DR BioSample; SAMN03472585
DR BioSample; SAMN03472993
DR CCLE; NCIH1581_LUNG
DR ChEMBL-Cells; CHEMBL3308765
DR ChEMBL-Targets; CHEMBL1075516
DR Cosmic; 687797
DR Cosmic; 877426
DR Cosmic; 844597
DR Cosmic; 980977
DR Cosmic; 908471
DR Cosmic; 1032449
DR Cosmic; 1152510
DR Cosmic; 1995527
DR Cosmic; 2009534
DR Cosmic-CLP; 908471
DR GDSC; 908471
DR GEO; GSM827484
DR GEO; GSM844622
DR GEO; GSM887369
DR GEO; GSM888447
DR GEO; GSM1670178
DR IGRhCellID; NCIH1581
DR KCLB; 91581
RX PubMed=1563005;
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y (ATCC)
ST Amelogenin: X (Cosmic-CLP; PubMed=25877200)
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9
ST D18S51: 15
ST D21S11: 29,31
ST D3S1358: 14
ST D5S818: 12
ST D7S820: 9,11
ST D8S1179: 10,14
ST FGA: 22
ST Penta D: 13
ST Penta E: 12,17
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 15,16 (ATCC; Cosmic-CLP)
ST vWA: 16 (PubMed=25877200)
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1592
AC CVCL_A501
SY H1592; H-1592
RX PubMed=8806092;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1607
AC CVCL_A467
SY H1607; H-1607
DR Cosmic; 844576
DR Cosmic; 877225
DR Cosmic; 877382
DR Cosmic; 1021877
DR Cosmic; 1152485
DR Cosmic; 1239944
DR Cosmic; 1518103
DR Cosmic; 2125232
DR GEO; GSM794322
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=19472407;
RX PubMed=20679594;
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 11,13
ST D5S818: 12
ST D7S820: 8
ST TH01: 9.3
ST TPOX: 8,10,11
ST vWA: 17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2642 ! NCI-BL1607
SX Male
CA Cancer cell line
//
ID NCI-H1608
AC CVCL_A502
SY H1608; H-1608
RX PubMed=8806092;
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1618
AC CVCL_1480
SY H1618; H-1618
DR CLO; CLO_0008004
DR EFO; EFO_0002258
DR ATCC; CRL-5879
DR BioSample; SAMN03472586
DR CCLE; NCIH1618_LUNG
DR ChEMBL-Cells; CHEMBL3308314
DR ChEMBL-Targets; CHEMBL2366290
DR Cosmic; 753601
DR Cosmic; 877226
DR Cosmic; 877383
DR Cosmic; 980950
DR Cosmic; 1004694
DR Cosmic; 1032420
DR Cosmic; 1239950
DR Cosmic; 2125233
DR GDSC; 753601
DR GEO; GSM380479
DR GEO; GSM380513
DR GEO; GSM887370
DR GEO; GSM888448
DR IGRhCellID; NCIH1618
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 9
ST D16S539: 11,13
ST D5S818: 10
ST D7S820: 8
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1622
AC CVCL_4364
SY H1622; H-1622
DR ATCC; CRL-5880
DR BioSample; SAMN03152021
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=20143388;
WW http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388).
CC Discontinued: ATCC; CRL-5880; true.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 16
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1623
AC CVCL_1481
SY H1623; H-1623
DR CLO; CLO_0008005
DR EFO; EFO_0002259
DR ATCC; CRL-5881
DR BioSample; SAMN03472994
DR CCLE; NCIH1623_LUNG
DR ChEMBL-Cells; CHEMBL3308766
DR ChEMBL-Targets; CHEMBL1075517
DR Cosmic; 687798
DR Cosmic; 877427
DR Cosmic; 903596
DR Cosmic; 980978
DR Cosmic; 1032450
DR Cosmic; 1995528
DR Cosmic; 2125234
DR Cosmic-CLP; 687798
DR GDSC; 687798
DR GEO; GSM513942
DR GEO; GSM514328
DR GEO; GSM784268
DR GEO; GSM827557
DR GEO; GSM887371
DR GEO; GSM888449
DR GEO; GSM1374702
DR GEO; GSM1670179
DR IGRhCellID; NCIH1623
DR KCLB; 91623
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9
ST D13S317: 12
ST D16S539: 9,12
ST D18S51: 14
ST D21S11: 30.2,31.2
ST D3S1358: 18
ST D5S818: 12
ST D7S820: 8
ST D8S1179: 13,14
ST FGA: 20,23
ST Penta D: 14
ST Penta E: 7
ST TH01: 7
ST TPOX: 11
ST vWA: 15,19,20
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1628
AC CVCL_A503
SY H1628; H-1628
DR ATCC; CRL-5980
DR Cosmic; 980951
DR Cosmic; 1032421
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Discontinued: ATCC; CRL-5980; true.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1648
AC CVCL_1482
SY H1648; H-1648
DR CLO; CLO_0008006
DR EFO; EFO_0003119
DR ATCC; CRL-5882
DR BioSample; SAMN03473271
DR CCLE; NCIH1648_LUNG
DR ChEMBL-Cells; CHEMBL3308315
DR ChEMBL-Targets; CHEMBL2366214
DR Cosmic; 687799
DR Cosmic; 877244
DR Cosmic; 877428
DR Cosmic; 903597
DR Cosmic; 931372
DR Cosmic; 980979
DR Cosmic; 1028941
DR Cosmic; 1032451
DR Cosmic; 1146882
DR Cosmic; 1152511
DR Cosmic; 1154594
DR Cosmic; 1219083
DR Cosmic; 1239886
DR Cosmic; 1891893
DR Cosmic; 1995529
DR Cosmic; 2125235
DR Cosmic-CLP; 687799
DR GDSC; 687799
DR GEO; GSM62326
DR GEO; GSM253366
DR GEO; GSM434268
DR GEO; GSM794323
DR GEO; GSM887372
DR GEO; GSM888450
DR GEO; GSM1670180
DR IGRhCellID; H1648GEO
DR LINCS; 50032
RX PubMed=8806092;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 11
ST D18S51: 15
ST D21S11: 28,30
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 13
ST FGA: 23,24
ST Penta D: 9,11
ST Penta E: 11
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E097 ! NCI-BL1648
SX Male
CA Cancer cell line
//
ID NCI-H1650
AC CVCL_1483
SY H1650; H-1650; H1650_CO; NCIH1650
DR BTO; BTO:0005243
DR CLO; CLO_0008007
DR EFO; EFO_0002260
DR CLDB; cl7182
DR ATCC; CRL-5883
DR BioSample; SAMN03472182
DR CCLE; NCIH1650_LUNG
DR CCRID; 3111C0001CCC000251
DR CCRID; 3131C0001000700152
DR ChEMBL-Cells; CHEMBL3308800
DR ChEMBL-Targets; CHEMBL1075518
DR Cosmic; 687800
DR Cosmic; 877429
DR Cosmic; 903598
DR Cosmic; 1017829
DR Cosmic; 1028942
DR Cosmic; 1047096
DR Cosmic; 1128242
DR Cosmic; 1146883
DR Cosmic; 1212188
DR Cosmic; 1239904
DR Cosmic; 1571738
DR Cosmic; 1600606
DR Cosmic; 1741779
DR Cosmic; 1795296
DR Cosmic; 1802299
DR Cosmic; 1891894
DR Cosmic; 1995530
DR Cosmic; 2042866
DR Cosmic; 2125236
DR Cosmic-CLP; 687800
DR GDSC; 687800
DR GEO; GSM206474
DR GEO; GSM253384
DR GEO; GSM434313
DR GEO; GSM782115
DR GEO; GSM784207
DR GEO; GSM794324
DR GEO; GSM827475
DR GEO; GSM844623
DR GEO; GSM887373
DR GEO; GSM888451
DR GEO; GSM1374703
DR GEO; GSM1670181
DR ICLC; HTL06002
DR IGRhCellID; H1650_COGEO
DR IGRhCellID; NCIH1650
DR KCLB; 91650
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=22433462;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 42 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 10
ST D21S11: 30
ST D3S1358: 18
ST D5S818: 11
ST D7S820: 8,9
ST D8S1179: 12
ST FGA: 20,23.2 (KCLB)
ST FGA: 20 (PubMed=25877200)
ST Penta D: 8
ST Penta E: 12
ST TH01: 9.3
ST TPOX: 11
ST vWA: 18
DI NCIt; C2923; Bronchioloalveolar carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1650-Luc
AC CVCL_4W95
DR JCRB; JCRB1478
DR JCRB; NIHS0723
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 8,9
ST TH01: 9.3
ST TPOX: 11
ST vWA: 18
DI NCIt; C2923; Bronchioloalveolar carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1483 ! NCI-H1650
SX Male
CA Cancer cell line
//
ID NCI-H1651
AC CVCL_1484
SY H1651; H-1651; NCIH1651
DR CLO; CLO_0008008
DR EFO; EFO_0002261
DR ATCC; CRL-5884
DR BioSample; SAMN03472590
DR CCLE; NCIH1651_LUNG
DR ChEMBL-Cells; CHEMBL3308383
DR ChEMBL-Targets; CHEMBL1075519
DR Cosmic; 687801
DR Cosmic; 910900
DR Cosmic; 1609525
DR Cosmic; 1802316
DR Cosmic; 1995531
DR Cosmic-CLP; 910900
DR GDSC; 910900
DR GEO; GSM206475
DR GEO; GSM513975
DR GEO; GSM514329
DR GEO; GSM794325
DR GEO; GSM827529
DR GEO; GSM844624
DR GEO; GSM887374
DR GEO; GSM888452
DR GEO; GSM1374704
DR GEO; GSM1670182
DR IGRhCellID; NCIH1651
DR LINCS; 50033
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 11
ST D16S539: 11
ST D18S51: 17
ST D21S11: 31.2
ST D3S1358: 17
ST D5S818: 12,14
ST D7S820: 8
ST D8S1179: 14,15
ST FGA: 24
ST Penta D: 13
ST Penta E: 12,16,17
ST TH01: 8
ST TPOX: 11
ST vWA: 18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1652
AC CVCL_A504
SY H1652; H-1652
RX PubMed=8806092;
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1666
AC CVCL_1485
SY H1666; H-1666; H1666_DA; NCIH1666
DR CLO; CLO_0008009
DR EFO; EFO_0002262
DR ATCC; CRL-5885
DR BioSample; SAMN03472948
DR CCLE; NCIH1666_LUNG
DR ChEMBL-Cells; CHEMBL3308118
DR ChEMBL-Targets; CHEMBL1075520
DR Cosmic; 684679
DR Cosmic; 877245
DR Cosmic; 897729
DR Cosmic; 908473
DR Cosmic; 914945
DR Cosmic; 980980
DR Cosmic; 1032452
DR Cosmic; 1146884
DR Cosmic; 1209729
DR Cosmic; 1477421
DR Cosmic; 1600604
DR Cosmic; 1995532
DR Cosmic; 2042869
DR Cosmic-CLP; 908473
DR GDSC; 908473
DR GEO; GSM206476
DR GEO; GSM253346
DR GEO; GSM434303
DR GEO; GSM794326
DR GEO; GSM827579
DR GEO; GSM844625
DR GEO; GSM844626
DR GEO; GSM844627
DR GEO; GSM887375
DR GEO; GSM888453
DR GEO; GSM1374705
DR GEO; GSM1670183
DR IGRhCellID; H1666_DAGEO
DR IGRhCellID; NCIH1666
DR KCLB; 25885
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 15
ST D16S539: 13
ST D18S51: 14
ST D21S11: 29,32.2
ST D3S1358: 16,18
ST D5S818: 10
ST D7S820: 8,11
ST D8S1179: 13,14
ST FGA: 20.2,21
ST Penta D: 10
ST Penta E: 14
ST TH01: 8,9.3
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C2923; Bronchioloalveolar carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1670
AC CVCL_A505
SY H1670; H-1670
RX PubMed=8806092;
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1672
AC CVCL_1486
SY H1672; H-1672
DR BTO; BTO:0005975
DR CLO; CLO_0008010
DR ATCC; CRL-5886
DR BioSample; SAMN03473009
DR Cosmic; 688005
DR Cosmic; 852002
DR Cosmic; 877227
DR Cosmic; 980952
DR Cosmic; 1021878
DR Cosmic; 1032422
DR Cosmic; 1759264
DR Cosmic; 1891912
DR Cosmic; 2125237
DR GEO; GSM794327
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 11
ST D18S51: 13,14
ST D21S11: 29,32.2
ST D3S1358: 18
ST D5S818: 11,13
ST D7S820: 10
ST D8S1179: 11,14
ST FGA: 21
ST Penta D: 8,12
ST Penta E: 9
ST TH01: 10
ST TPOX: 11
ST vWA: 17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2643 ! NCI-BL1672
SX Male
CA Cancer cell line
//
ID NCI-H1684
AC CVCL_3972
SY H1684; H-1684
DR BTO; BTO:0003243
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1688
AC CVCL_1487
SY H1688; H-1688; NCIH1688
DR BTO; BTO:0005966
DR CLO; CLO_0008011
DR ATCC; CCL-257
DR BCRC; 60497
DR BioSample; SAMN03471387
DR CCRID; 3131C0001000700154
DR Cosmic; 1995533
DR Cosmic-CLP; 1298349
DR GDSC; 1298349
DR GEO; GSM784264
DR GEO; GSM986174
DR GEO; GSM1670184
DR KCLB; 91688
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10037197;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 13
ST D5S818: 10
ST D7S820: 12
ST TH01: 6,8
ST TPOX: 11
ST vWA: 17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E098 ! NCI-BL1688
SX Male
CA Cancer cell line
//
ID NCI-H1693
AC CVCL_1488
SY H1693; H-1693
DR CLO; CLO_0008012
DR EFO; EFO_0006661
DR ATCC; CRL-5887
DR BioSample; SAMN03472587
DR CCLE; NCIH1693_LUNG
DR ChEMBL-Cells; CHEMBL3308458
DR ChEMBL-Targets; CHEMBL1075521
DR Cosmic; 687802
DR Cosmic; 877430
DR Cosmic; 903599
DR Cosmic; 980981
DR Cosmic; 1032453
DR Cosmic; 1995534
DR Cosmic-CLP; 687802
DR GDSC; 687802
DR GEO; GSM513943
DR GEO; GSM514330
DR GEO; GSM784269
DR GEO; GSM794328
DR GEO; GSM827560
DR GEO; GSM887376
DR GEO; GSM888454
DR GEO; GSM1670185
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 11
ST D16S539: 10
ST D5S818: 10,12
ST D7S820: 9,10
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1694
AC CVCL_1489
SY H1694; H-1694
DR CLO; CLO_0008013
DR EFO; EFO_0002263
DR ATCC; CRL-5888
DR BioSample; SAMN03473010
DR CCLE; NCIH1694_LUNG
DR ChEMBL-Cells; CHEMBL3308555
DR ChEMBL-Targets; CHEMBL2366333
DR Cosmic; 688006
DR Cosmic; 1995535
DR Cosmic-CLP; 688006
DR GDSC; 688006
DR GEO; GSM887377
DR GEO; GSM888455
DR GEO; GSM1670186
DR GEO; GSM1682806
DR IGRhCellID; NCIH1694
RX PubMed=1563005;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9,11
ST D18S51: 15,17
ST D21S11: 29
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 11
ST D8S1179: 12,13
ST FGA: 25
ST Penta D: 13
ST Penta E: 11,12
ST TH01: 6,9
ST TPOX: 11
ST vWA: 15,16
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1703
AC CVCL_1490
SY H1703; H-1703; NCIH1703
DR BTO; BTO:0003009
DR CLO; CLO_0008014
DR EFO; EFO_0002264
DR ATCC; CRL-5889
DR BioSample; SAMN03472937
DR CCLE; NCIH1703_LUNG
DR CCRID; 3111C0001CCC000353
DR ChEMBL-Cells; CHEMBL3308503
DR ChEMBL-Targets; CHEMBL1075522
DR Cosmic; 687803
DR Cosmic; 903600
DR Cosmic; 908474
DR Cosmic; 980982
DR Cosmic; 1017827
DR Cosmic; 1028952
DR Cosmic; 1032454
DR Cosmic; 1202065
DR Cosmic; 1219064
DR Cosmic; 1239887
DR Cosmic; 1870265
DR Cosmic; 1995536
DR Cosmic; 2009535
DR Cosmic; 2042871
DR Cosmic; 2125180
DR Cosmic-CLP; 908474
DR GDSC; 908474
DR GEO; GSM206477
DR GEO; GSM434786
DR GEO; GSM784217
DR GEO; GSM794329
DR GEO; GSM827485
DR GEO; GSM844628
DR GEO; GSM887378
DR GEO; GSM888456
DR GEO; GSM1374706
DR GEO; GSM1374707
DR GEO; GSM1670187
DR IGRhCellID; NCIH1703
DR KCLB; 91703
DR LINCS; 50034
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=24805778;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.addexbio.com/productdetail?pid=4676
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 10
ST D16S539: 10,12
ST D18S51: 17,18
ST D21S11: 29
ST D3S1358: 16,17
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 11,13
ST FGA: 20
ST Penta D: 10
ST Penta E: 10,12
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1710
AC CVCL_A506
SY H1710; H-1710
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C2923; Bronchioloalveolar carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1717
AC CVCL_A507
SY H1717; H-1717
DR ATCC; CRL-5890
DR BioSample; SAMN03472588
RX PubMed=8806092;
RX PubMed=11030152;
CC Discontinued: ATCC; CRL-5890; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 12
ST D5S818: 13
ST D7S820: 8,9
ST TH01: 9
ST TPOX: 8
ST vWA: 15,19
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1725
AC CVCL_A508
SY H1725; H-1725
DR Cosmic; 722051
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1726
AC CVCL_A476
SY H1726; H-1726
DR Cosmic; 877431
DR Cosmic; 1152512
RX PubMed=8806092;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H1734
AC CVCL_1491
SY H1734; H-1734
DR CLO; CLO_0008015
DR EFO; EFO_0006662
DR ATCC; CRL-5891
DR BioSample; SAMN03471721
DR CCLE; NCIH1734_LUNG
DR ChEMBL-Cells; CHEMBL3308767
DR ChEMBL-Targets; CHEMBL1075523
DR Cosmic; 722058
DR Cosmic; 1146885
DR Cosmic; 1609515
DR Cosmic; 1995537
DR Cosmic-CLP; 722058
DR GDSC; 722058
DR GEO; GSM434328
DR GEO; GSM513944
DR GEO; GSM514331
DR GEO; GSM794330
DR GEO; GSM827507
DR GEO; GSM887379
DR GEO; GSM888457
DR GEO; GSM1374708
DR GEO; GSM1670188
DR IGRhCellID; H1734GEO
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=24135919;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 11,12
ST D16S539: 12
ST D18S51: 13,15
ST D21S11: 33.2
ST D3S1358: 16
ST D5S818: 10
ST D7S820: 10,11
ST D8S1179: 13
ST FGA: 24
ST Penta D: 11
ST Penta E: 12,14
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1755
AC CVCL_1492
SY H1755; H-1755; NCIH1755
DR CLO; CLO_0008016
DR ATCC; CRL-5892
DR BioSample; SAMN03472589
DR CCLE; NCIH1755_LUNG
DR ChEMBL-Cells; CHEMBL3308768
DR ChEMBL-Targets; CHEMBL1075524
DR Cosmic; 684677
DR Cosmic; 684678
DR Cosmic; 903601
DR Cosmic; 908475
DR Cosmic; 980983
DR Cosmic; 1032455
DR Cosmic; 1146886
DR Cosmic; 1209732
DR Cosmic; 1477423
DR Cosmic; 1995538
DR Cosmic; 2472918
DR Cosmic-CLP; 908475
DR GDSC; 908475
DR GEO; GSM434279
DR GEO; GSM513945
DR GEO; GSM514332
DR GEO; GSM794331
DR GEO; GSM827558
DR GEO; GSM887380
DR GEO; GSM888458
DR GEO; GSM1374709
DR GEO; GSM1670189
DR IGRhCellID; NCIH1755
DR KCLB; 91755
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=24805778;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Liver.
ST Source(s): ATCC; Cosmic-CLP; KCLB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,12
ST D16S539: 11,12
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 12
ST FGA: 20,25
ST TH01: 7
ST TPOX: 8
ST vWA: 18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1755A
AC CVCL_L169
SY H1755A; H-1755A
DR KCLB; 91755A
CC Derived from metastatic site: Liver.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1492 ! NCI-H1755
SX Female
CA Cancer cell line
//
ID NCI-H1769
AC CVCL_A509
SY H1769; H-1769
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1770
AC CVCL_1493
SY H1770; H-1770; NCIH1770
DR CLO; CLO_0008017
DR EFO; EFO_0002265
DR ATCC; CRL-5893
DR BioSample; SAMN03473294
DR ChEMBL-Cells; CHEMBL3308316
DR ChEMBL-Targets; CHEMBL2366171
DR Cosmic; 687804
DR Cosmic; 877269
DR Cosmic; 980984
DR Cosmic; 1004695
DR Cosmic; 1032456
DR Cosmic; 1146887
DR Cosmic; 1239953
DR Cosmic; 1802298
DR Cosmic; 1891895
DR Cosmic; 1995539
DR Cosmic; 2125213
DR Cosmic-CLP; 687804
DR GDSC; 687804
DR GEO; GSM434304
DR GEO; GSM844629
DR GEO; GSM1670190
DR IGRhCellID; NCIH1770
RX PubMed=8806092;
RX PubMed=10987304;
RX PubMed=11314036;
RX PubMed=16157194;
RX PubMed=19472407;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/LungCellLineDescriptions/NCI-H1770.html
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=11416159; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 13
ST D16S539: 12,13
ST D18S51: 14,16
ST D21S11: 30,32.2
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 11
ST D8S1179: 13,14
ST FGA: 20
ST Penta D: 9,10
ST Penta E: 7,12
ST TH01: 9
ST TPOX: 11
ST vWA: 18,19
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2644 ! NCI-BL1770
SX Male
CA Cancer cell line
//
ID NCI-H1781
AC CVCL_1494
SY H1781; H-1781; NCIH1781
DR CLO; CLO_0008018
DR EFO; EFO_0006663
DR ATCC; CRL-5894
DR BioSample; SAMN03471698
DR CCLE; NCIH1781_LUNG
DR Cosmic; 877432
DR Cosmic; 897517
DR Cosmic; 897728
DR Cosmic; 903568
DR Cosmic; 914946
DR Cosmic; 980985
DR Cosmic; 1032457
DR Cosmic; 1128243
DR Cosmic; 1146888
DR Cosmic; 1802296
DR Cosmic; 1995540
DR Cosmic-CLP; 1298350
DR GDSC; 1298350
DR GEO; GSM206478
DR GEO; GSM253348
DR GEO; GSM434280
DR GEO; GSM794333
DR GEO; GSM827359
DR GEO; GSM887381
DR GEO; GSM888459
DR GEO; GSM1374710
DR GEO; GSM1670191
DR IGRhCellID; H1781GEO
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'NSI-H1781' in Cosmic 897517.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 14
ST D16S539: 8
ST D18S51: 14
ST D21S11: 28,31
ST D3S1358: 15
ST D5S818: 10
ST D7S820: 9,10
ST D8S1179: 14
ST FGA: 22,23
ST Penta D: 11,13
ST Penta E: 17
ST TH01: 9
ST TPOX: 10,11
ST vWA: 14
DI NCIt; C2923; Bronchioloalveolar carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1788
AC CVCL_A510
SY H1788; H-1788
DR ATCC; CRL-5981
DR Cosmic; 1891913
RX PubMed=8806092;
RX PubMed=8806103;
CC Discontinued: ATCC; CRL-5981; true.
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1792
AC CVCL_1495
SY H1792; H-1792; NCIH1792
DR BTO; BTO:0005836
DR CLO; CLO_0008019
DR EFO; EFO_0002266
DR ATCC; CRL-5895
DR BioSample; SAMN03470834
DR CCLE; NCIH1792_LUNG
DR ChEMBL-Cells; CHEMBL3308816
DR ChEMBL-Targets; CHEMBL1075525
DR Cosmic; 722044
DR Cosmic; 724868
DR Cosmic; 877246
DR Cosmic; 877433
DR Cosmic; 903603
DR Cosmic; 980986
DR Cosmic; 1032458
DR Cosmic; 1146889
DR Cosmic; 1152513
DR Cosmic; 1891896
DR Cosmic; 1995541
DR Cosmic-CLP; 724868
DR GDSC; 724868
DR GEO; GSM253305
DR GEO; GSM434329
DR GEO; GSM784206
DR GEO; GSM784257
DR GEO; GSM794334
DR GEO; GSM827476
DR GEO; GSM887382
DR GEO; GSM888460
DR GEO; GSM1670192
DR IGRhCellID; NCIH1792
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=24135919;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 45 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 10,11
ST D18S51: 15,17
ST D21S11: 31
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 8,11
ST D8S1179: 12,15
ST FGA: 22,24
ST Penta D: 13
ST Penta E: 8,10
ST TH01: 7
ST TPOX: 11
ST vWA: 14,16
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1793
AC CVCL_1496
SY H1793; H-1793
DR CLO; CLO_0008020
DR EFO; EFO_0002267
DR ATCC; CRL-5896
DR BioSample; SAMN03472601
DR CCLE; NCIH1793_LUNG
DR ChEMBL-Cells; CHEMBL3308579
DR ChEMBL-Targets; CHEMBL1075526
DR Cosmic; 687806
DR Cosmic; 903604
DR Cosmic; 908463
DR Cosmic; 1609519
DR Cosmic; 1995542
DR Cosmic-CLP; 908463
DR GDSC; 908463
DR GEO; GSM206479
DR GEO; GSM513946
DR GEO; GSM514333
DR GEO; GSM784270
DR GEO; GSM794335
DR GEO; GSM827508
DR GEO; GSM887383
DR GEO; GSM888461
DR GEO; GSM1374711
DR GEO; GSM1670193
DR IGRhCellID; NCIH1793
DR KCLB; 91793
RX PubMed=8806092;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 8,12
ST D16S539: 13
ST D18S51: 10,18
ST D21S11: 28
ST D3S1358: 17,18
ST D5S818: 11,12
ST D7S820: 7,8
ST D8S1179: 8,13
ST FGA: 23,24 (KCLB)
ST FGA: 23.2,24 (PubMed=25877200)
ST Penta D: 13,14
ST Penta E: 14,16
ST TH01: 9,9.3 (ATCC; Cosmic-CLP; PubMed=25877200)
ST TH01: 9 (KCLB)
ST TPOX: 8
ST vWA: 18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1819
AC CVCL_1497
SY H1819; H-1819
DR CLO; CLO_0008021
DR ATCC; CRL-5897
DR Cosmic; 877247
DR Cosmic; 877434
DR Cosmic; 903605
DR Cosmic; 1146890
DR Cosmic; 1152514
DR Cosmic; 1219065
DR Cosmic; 1239888
DR Cosmic; 2125181
DR GEO; GSM62327
DR GEO; GSM253312
DR GEO; GSM434252
DR GEO; GSM794336
DR IGRhCellID; H1819_02%20GEO
RX PubMed=8806092;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=19472407;
RX PubMed=20679594;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; PubMed=11416159; PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 11
ST D16S539: 10
ST D18S51: 15
ST D21S11: 29
ST D5S818: 10,12
ST D7S820: 9,10
ST D8S1179: 12,15
ST FGA: 22
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E099 ! NCI-BL1819
SX Female
CA Cancer cell line
//
ID NCI-H182
AC CVCL_A511
SY H182; H-182
DR Cosmic; 844548
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1824
AC CVCL_A512
SY H1824; H-1824
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E100 ! NCI-BL1824
SX Male
CA Cancer cell line
//
ID NCI-H1836
AC CVCL_1498
SY H1836; H-1836
DR CLO; CLO_0008022
DR ATCC; CRL-5898
DR BioSample; SAMN03472591
DR CCLE; NCIH1836_LUNG
DR Cosmic; 980953
DR Cosmic; 1032423
DR Cosmic; 1759267
DR Cosmic-CLP; 1240182
DR GDSC; 1240182
DR GEO; GSM887384
DR GEO; GSM888462
DR GEO; GSM986175
DR GEO; GSM1670194
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,12
ST D16S539: 11,13
ST D5S818: 11
ST D7S820: 11,12
ST TH01: 8,9.3
ST TPOX: 9,10
ST vWA: 16
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1838
AC CVCL_1499
SY H1838; H-1838; NCIH1838
DR BTO; BTO:0005779
DR CLO; CLO_0008023
DR EFO; EFO_0002268
DR ATCC; CRL-5899
DR BioSample; SAMN03471784
DR CCLE; NCIH1838_LUNG
DR ChEMBL-Cells; CHEMBL3308317
DR ChEMBL-Targets; CHEMBL2366346
DR Cosmic; 687807
DR Cosmic; 877435
DR Cosmic; 980987
DR Cosmic; 1032459
DR Cosmic; 1146891
DR Cosmic; 1152515
DR Cosmic; 1995543
DR Cosmic-CLP; 687807
DR GDSC; 687807
DR GEO; GSM206480
DR GEO; GSM434330
DR GEO; GSM513949
DR GEO; GSM514334
DR GEO; GSM784224
DR GEO; GSM794337
DR GEO; GSM887385
DR GEO; GSM888463
DR GEO; GSM1374712
DR GEO; GSM1374713
DR GEO; GSM1670195
DR IGRhCellID; NCIH1838
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 13
ST D18S51: 17
ST D21S11: 29
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 8
ST D8S1179: 14
ST FGA: 20,23.2
ST Penta D: 9,13
ST Penta E: 12
ST TH01: 8
ST TPOX: 8
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1869
AC CVCL_1500
SY H1869; H-1869; NCIH1869
DR CLO; CLO_0008024
DR EFO; EFO_0006664
DR ATCC; CRL-5900
DR BioSample; SAMN03472995
DR CCLE; NCIH1869_LUNG
DR Cosmic; 1995544
DR Cosmic-CLP; 1240183
DR GDSC; 1240183
DR GEO; GSM434787
DR GEO; GSM794338
DR GEO; GSM844630
DR GEO; GSM844631
DR GEO; GSM887386
DR GEO; GSM888464
DR GEO; GSM1374714
DR GEO; GSM1374715
DR GEO; GSM1670196
RX PubMed=8806092;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12
ST D18S51: 12,18
ST D21S11: 31
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 8,9
ST D8S1179: 13,14
ST FGA: 22
ST Penta D: 11
ST Penta E: 7,10
ST TH01: 6
ST TPOX: 8,9
ST vWA: 16
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H187
AC CVCL_1501
SY H187; H-187; NCIH187
DR BTO; BTO:0003021
DR CLO; CLO_0008025
DR EFO; EFO_0002269
DR ATCC; CRL-5804
DR BioSample; SAMN03471879
DR ChEMBL-Cells; CHEMBL3308878
DR ChEMBL-Targets; CHEMBL2366276
DR Cosmic; 688007
DR Cosmic; 844549
DR Cosmic; 850441
DR Cosmic; 877201
DR Cosmic; 877353
DR Cosmic; 1006524
DR Cosmic; 1021854
DR Cosmic; 1152463
DR Cosmic; 1219099
DR Cosmic; 1998283
DR Cosmic; 2125193
DR Cosmic-CLP; 688007
DR GDSC; 688007
DR GEO; GSM169435
DR GEO; GSM380510
DR GEO; GSM380514
DR GEO; GSM482516
DR GEO; GSM536329
DR GEO; GSM784232
DR GEO; GSM794275
DR GEO; GSM844632
DR GEO; GSM845554
DR GEO; GSM986173
DR GEO; GSM1670197
DR IGRhCellID; NCIH187
DR KCLB; 90187
RX PubMed=1563005;
RX PubMed=2985257;
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10037197;
RX PubMed=11030152;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-291.html
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'NCIN187' in GEO GSM845554.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 11
ST D18S51: 16
ST D21S11: 28,29
ST D3S1358: 14
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 14
ST FGA: 25
ST Penta D: 8,16
ST Penta E: 12,15
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1870
AC CVCL_1502
SY H1870; H-1870
DR CLO; CLO_0008026
DR ATCC; CRL-5901
DR BioSample; SAMN03151856
DR BioSample; SAMN03472592
DR Cosmic; 1021879
DR GEO; GSM168280
RX PubMed=8806092;
RX PubMed=8806103;
WW http://www.atcc.org/support/faqs/d2b8d/NCIH1304%20ATCC%20CRL5862-1069.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. NCI-H1304 and NCI-H1870 have been shown to be identical.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-5901; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 14
ST D16S539: 11
ST D5S818: 11
ST D7S820: 9,12
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1462 ! NCI-H1304
SX Female
CA Cancer cell line
//
ID NCI-H1876
AC CVCL_1503
SY H1876; H-1876
DR CLO; CLO_0008027
DR ATCC; CRL-5902
DR CCLE; NCIH1876_LUNG
DR Cosmic; 877384
DR Cosmic; 1032424
DR Cosmic; 1152486
DR Cosmic; 1891914
DR Cosmic-CLP; 1330972
DR GDSC; 1330972
DR GEO; GSM887387
DR GEO; GSM888465
DR GEO; GSM986179
DR GEO; GSM1670198
DR GEO; GSM1682808
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 12
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 6
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A513 ! NCI-H1881
OI CVCL_1504 ! NCI-H1882
SX Male
CA Cancer cell line
//
ID NCI-H1881
AC CVCL_A513
SY H1881; H-1881
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1503 ! NCI-H1876
OI CVCL_1504 ! NCI-H1882
SX Male
CA Cancer cell line
//
ID NCI-H1882
AC CVCL_1504
SY H1882; H-1882
DR CLO; CLO_0008028
DR EFO; EFO_0006665
DR ATCC; CRL-5903
DR BioSample; SAMN03473011
DR ChEMBL-Cells; CHEMBL3308318
DR ChEMBL-Targets; CHEMBL2366210
DR Cosmic; 753602
DR Cosmic; 877228
DR Cosmic; 980954
DR Cosmic; 1032425
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 12
ST D18S51: 18
ST D21S11: 29
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 12,14
ST FGA: 21,24
ST Penta D: 12,13
ST Penta E: 13
ST TH01: 6
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1503 ! NCI-H1876
OI CVCL_A513 ! NCI-H1881
SX Male
CA Cancer cell line
//
ID NCI-H1904
AC CVCL_A514
SY H1904; H-1904
RX PubMed=8806092;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1915
AC CVCL_1505
SY H1915; H-1915
DR BTO; BTO:0004426
DR CLO; CLO_0008029
DR EFO; EFO_0006666
DR ATCC; CRL-5904
DR BioSample; SAMN03473019
DR CCLE; NCIH1915_LUNG
DR Cosmic; 722067
DR Cosmic; 1146892
DR Cosmic; 1995545
DR Cosmic-CLP; 1240184
DR GDSC; 1240184
DR GEO; GSM434314
DR GEO; GSM827393
DR GEO; GSM887388
DR GEO; GSM888466
DR GEO; GSM1670199
DR IGRhCellID; H1915GEO
DR KCLB; 91915
DR LINCS; 50035
DR PRIDE; PXD002556
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=26361996;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 91915; probable.
ST Source(s): ATCC; Cosmic-CLP; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 9
ST D18S51: 11
ST D21S11: 27
ST D3S1358: 15,18
ST D5S818: 12
ST D7S820: 11,12
ST D8S1179: 10
ST FGA: 20
ST Penta D: 13
ST Penta E: 10
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1926
AC CVCL_1506
SY H1926; H-1926
DR CLO; CLO_0008030
DR ATCC; CRL-5905
DR BioSample; SAMN03472593
DR Cosmic; 688008
DR Cosmic; 850432
DR Cosmic; 908477
DR GDSC; 908477
RX PubMed=1563005;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=20679594;
ST Source(s): ATCC; PubMed=20679594
ST Amelogenin: X (ATCC)
ST Amelogenin: X,Y (PubMed=20679594)
ST CSF1PO: 10,11
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 13
ST D7S820: 10,12
ST TH01: 9
ST TPOX: 9,11
ST vWA: 17,19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1930
AC CVCL_1507
SY H1930; H-1930
DR CLO; CLO_0008031
DR EFO; EFO_0002270
DR ATCC; CRL-5906
DR BioSample; SAMN03473063
DR CCLE; NCIH1930_LUNG
DR Cosmic; 688009
DR Cosmic; 844575
DR Cosmic; 877229
DR Cosmic; 924245
DR Cosmic; 2125238
DR GEO; GSM380480
DR GEO; GSM887389
DR GEO; GSM888467
DR IGRhCellID; NCIH1930
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 11
ST D18S51: 12,19
ST D21S11: 30
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 9,10
ST D8S1179: 12,14
ST FGA: 21
ST Penta D: 11
ST Penta E: 7,13
ST TH01: 6,10
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1934
AC CVCL_A515
SY H1934; H-1934
RX PubMed=8806092;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1944
AC CVCL_1508
SY H1944; H-1944
DR BTO; BTO:0005837
DR CLO; CLO_0008032
DR EFO; EFO_0006667
DR ATCC; CRL-5907
DR BioSample; SAMN03473281
DR CCLE; NCIH1944_LUNG
DR Cosmic; 722062
DR Cosmic; 903606
DR Cosmic; 1146893
DR Cosmic; 1891897
DR Cosmic-CLP; 1240185
DR GDSC; 1240185
DR GEO; GSM434331
DR GEO; GSM513950
DR GEO; GSM514335
DR GEO; GSM794339
DR GEO; GSM827486
DR GEO; GSM887390
DR GEO; GSM888468
DR GEO; GSM1670200
DR IGRhCellID; H1944GEO
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 11
ST D16S539: 11
ST D18S51: 18,19
ST D21S11: 28,31
ST D3S1358: 15,18
ST D5S818: 11
ST D7S820: 11,12
ST D8S1179: 14,15
ST FGA: 21,25
ST Penta D: 8,11
ST Penta E: 5,11
ST TH01: 6,7
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1954
AC CVCL_A516
SY H1954; H-1954
RX PubMed=8806092;
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H196
AC CVCL_1509
SY H196; H-196; NCIH196
DR BTO; BTO:0003027
DR CLO; CLO_0008033
DR EFO; EFO_0006668
DR ATCC; CRL-5823
DR BioSample; SAMN03471881
DR CCLE; NCIH196_LUNG
DR Cosmic; 852003
DR Cosmic; 953990
DR Cosmic; 1995546
DR Cosmic-CLP; 1240186
DR GDSC; 1240186
DR GEO; GSM169451
DR GEO; GSM784210
DR GEO; GSM827362
DR GEO; GSM845541
DR GEO; GSM844633
DR GEO; GSM887392
DR GEO; GSM888470
DR GEO; GSM986170
DR GEO; GSM1670201
DR KCLB; 90196
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 64 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 90196; probable.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 9
ST D16S539: 11
ST D18S51: 17,19
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 13,15
ST FGA: 22,23
ST Penta D: 10
ST Penta E: 8,12
ST TH01: 6
ST TPOX: 11
ST vWA: 19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1963
AC CVCL_1510
SY H1963; H-1963; NCIH1963
DR BTO; BTO:0005976
DR CLO; CLO_0008034
DR ATCC; CRL-5982
DR BioSample; SAMN03472631
DR BioSample; SAMN03473530
DR CCLE; NCIH1963_LUNG
DR ChEMBL-Cells; CHEMBL3308855
DR ChEMBL-Targets; CHEMBL2366075
DR Cosmic; 688010
DR Cosmic; 877230
DR Cosmic; 1021880
DR Cosmic; 1219106
DR Cosmic; 1239945
DR Cosmic; 1995547
DR Cosmic; 2125206
DR Cosmic-CLP; 688010
DR DSMZ; ACC-540
DR GDSC; 688010
DR GEO; GSM169429
DR GEO; GSM845542
DR GEO; GSM844634
DR GEO; GSM844635
DR GEO; GSM887391
DR GEO; GSM888469
DR GEO; GSM1670202
DR GEO; GSM1682809
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~3-4 days (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; DSMZ
ST Amelogenin: X,Y (ATCC; Cosmic-CLP)
ST Amelogenin: X (DSMZ)
ST CSF1PO: 12
ST D13S317: 11,13
ST D16S539: 11
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 6,8
ST TPOX: 8,10
ST vWA: 17,20
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E101 ! NCI-BL1963
SX Male
CA Cancer cell line
//
ID NCI-H1968
AC CVCL_A517
SY H1968; H-1968
RX PubMed=8806092;
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1971
AC CVCL_A518
SY H1971; H-1971
RX PubMed=8806092;
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1974
AC CVCL_A519
SY H1974; H-1974
RX PubMed=8806092;
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1975
AC CVCL_1511
SY H1975; H-1975
DR BTO; BTO:0004824
DR CLO; CLO_0008035
DR EFO; EFO_0002271
DR CLDB; cl7204
DR ATCC; CRL-5908
DR BCRJ; 0352
DR BioSample; SAMN03471753
DR BioSample; SAMN03472594
DR CCLE; NCIH1975_LUNG
DR CCRID; 3111C0001CCC000252
DR ChEMBL-Cells; CHEMBL3307601
DR ChEMBL-Targets; CHEMBL614348
DR Cosmic; 687808
DR Cosmic; 903607
DR Cosmic; 924244
DR Cosmic; 930487
DR Cosmic; 1028949
DR Cosmic; 1047098
DR Cosmic; 1128244
DR Cosmic; 1146894
DR Cosmic; 1154595
DR Cosmic; 1336879
DR Cosmic; 1513408
DR Cosmic; 1571739
DR Cosmic; 1609518
DR Cosmic; 1741781
DR Cosmic; 1795297
DR Cosmic; 1802294
DR Cosmic; 1995548
DR Cosmic; 2042865
DR Cosmic; 2125194
DR Cosmic-CLP; 924244
DR GDSC; 924244
DR GEO; GSM206481
DR GEO; GSM253304
DR GEO; GSM434293
DR GEO; GSM513951
DR GEO; GSM514336
DR GEO; GSM782116
DR GEO; GSM794340
DR GEO; GSM887393
DR GEO; GSM888471
DR GEO; GSM1374716
DR GEO; GSM1670203
DR ICLC; HTL06001
DR IGRhCellID; NCIH1975
DR KCB; KCB 2014034YJ
DR PRIDE; PXD002224
RX PubMed=8806092;
RX PubMed=19727395;
RX PubMed=21498706;
RX PubMed=22460905;
RX PubMed=25008024;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=26202522;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 38.7 +- 5.92 hours (PubMed=25008024); 28 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep membrane proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,13 (ATCC; Cosmic-CLP)
ST D13S317: 10 (PubMed=25877200)
ST D16S539: 9,12
ST D18S51: 13
ST D21S11: 28
ST D3S1358: 14,15
ST D5S818: 11,12
ST D7S820: 8,11 (ATCC)
ST D7S820: 8 (Cosmic-CLP; PubMed=25877200)
ST D8S1179: 13,16
ST FGA: 21,24
ST Penta D: 12,13
ST Penta E: 12,16
ST TH01: 7
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1975-Luc
AC CVCL_4W96
DR JCRB; JCRB1486
DR JCRB; NIHS0724
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,13
ST D16S539: 9,12
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 7
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1511 ! NCI-H1975
SX Female
CA Cancer cell line
//
ID NCI-H1975/GR
AC CVCL_HF59
RX PubMed=25008024;
CC Doubling time: 47.73 +- 3.50 hours (PubMed=25008024).
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1511 ! NCI-H1975
SX Female
CA Cancer cell line
//
ID NCI-H1975/GR/XR
AC CVCL_HF60
RX PubMed=25008024;
CC Doubling time: 46.68 +- 2.68 hours (PubMed=25008024).
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
CC Transformant: NCIt; C17262; X-Ray.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_HF59 ! NCI-H1975/GR
SX Female
CA Cancer cell line
//
ID NCI-H1977
AC CVCL_A520
SY H1977; H-1977
RX PubMed=8806092;
DI NCIt; C7985; Epithelioid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1993
AC CVCL_1512
SY H1993; H-1993
DR CLO; CLO_0008036
DR EFO; EFO_0002272
DR ATCC; CRL-5909
DR BioSample; SAMN03473255
DR ChEMBL-Cells; CHEMBL3308138
DR ChEMBL-Targets; CHEMBL1075527
DR Cosmic; 687809
DR Cosmic; 877248
DR Cosmic; 903608
DR Cosmic; 908476
DR Cosmic; 980988
DR Cosmic; 1032460
DR Cosmic; 1146895
DR Cosmic; 1694669
DR Cosmic; 1870266
DR Cosmic; 1891898
DR Cosmic; 1995549
DR Cosmic; 2125239
DR Cosmic-CLP; 908476
DR GDSC; 908476
DR GEO; GSM62328
DR GEO; GSM434315
DR GEO; GSM513952
DR GEO; GSM514337
DR GEO; GSM794341
DR GEO; GSM1670204
DR IGRhCellID; NCIH1993
RX PubMed=8806092;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=20679594;
RX PubMed=24297535;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=20679594; PubMed=25877200
ST Amelogenin: X (ATCC; Cosmic-CLP; PubMed=25877200)
ST Amelogenin: X,Y (PubMed=20679594)
ST CSF1PO: 10,13
ST D13S317: 13
ST D16S539: 12
ST D18S51: 13,18
ST D21S11: 29
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 12
ST D8S1179: 14
ST FGA: 22,23
ST Penta D: 10
ST Penta E: 12
ST TH01: 6,9.3
ST TPOX: 9
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E102 ! NCI-BL1993
OI CVCL_1521 ! NCI-H2073
SX Female
CA Cancer cell line
//
ID NCI-H1994
AC CVCL_1513
SY H1994; H-1994
DR CLO; CLO_0008037
DR ATCC; CRL-5910
DR BioSample; SAMN03472595
RX PubMed=8806092;
RX PubMed=8806103;
CC Discontinued: ATCC; CRL-5910; true.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 12
ST D5S818: 10,11
ST D7S820: 9,11
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 15,19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1516 ! NCI-H2029
SX Female
CA Cancer cell line
//
ID NCI-H2007
AC CVCL_A521
SY H2007; H-2007
RX PubMed=8806092;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2009
AC CVCL_1514
SY H2009; H-2009
DR BTO; BTO:0003242
DR CLO; CLO_0008038
DR EFO; EFO_0002273
DR ATCC; CRL-5911
DR BioSample; SAMN03471794
DR CCLE; NCIH2009_LUNG
DR CCRID; 3111C0001CCC000383
DR ChEMBL-Cells; CHEMBL3308459
DR ChEMBL-Targets; CHEMBL1075528
DR Cosmic; 722054
DR Cosmic; 724873
DR Cosmic; 877249
DR Cosmic; 877436
DR Cosmic; 903609
DR Cosmic; 980989
DR Cosmic; 1032461
DR Cosmic; 1146896
DR Cosmic; 1154596
DR Cosmic; 1188589
DR Cosmic; 1239889
DR Cosmic; 1518084
DR Cosmic; 1802308
DR Cosmic; 1870267
DR Cosmic; 1891899
DR Cosmic; 1995550
DR Cosmic; 2125240
DR Cosmic-CLP; 724873
DR GDSC; 724873
DR GEO; GSM63697
DR GEO; GSM206482
DR GEO; GSM253369
DR GEO; GSM385518
DR GEO; GSM385529
DR GEO; GSM434316
DR GEO; GSM794342
DR GEO; GSM827528
DR GEO; GSM887394
DR GEO; GSM888472
DR GEO; GSM1670205
DR IGRhCellID; NCIH2009
DR KCLB; 92009
RX PubMed=8806092;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=16157194;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=24135919;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://www.pawefish.path.cam.ac.uk/LungCellLineDescriptions/NCI-H2009.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=11416159; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 12
ST D18S51: 14
ST D21S11: 29
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 9,11
ST D8S1179: 10,15
ST FGA: 22 (KCLB; PubMed=25877200)
ST FGA: 22,26 (PubMed=11416159)
ST Penta D: 12
ST Penta E: 11
ST TH01: 9.3
ST TPOX: 8
ST vWA: 14
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2645 ! NCI-BL2009
SX Female
CA Cancer cell line
//
ID NCI-H2009-Luc
AC CVCL_4Y15
DR JCRB; NIHS0725
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1514 ! NCI-H2009
SX Female
CA Cancer cell line
//
ID NCI-H2023
AC CVCL_1515
SY H2023; H-2023
DR CLO; CLO_0008039
DR EFO; EFO_0006669
DR ATCC; CRL-5912
DR BioSample; SAMN03472596
DR BioSample; SAMN03472996
DR CCLE; NCIH2023_LUNG
DR Cosmic; 903610
DR Cosmic; 1995551
DR Cosmic-CLP; 1240187
DR GDSC; 1240187
DR GEO; GSM513953
DR GEO; GSM514338
DR GEO; GSM784271
DR GEO; GSM794343
DR GEO; GSM827487
DR GEO; GSM887395
DR GEO; GSM888473
DR GEO; GSM1670206
DR LINCS; 50036
RX PubMed=8806092;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 17,18
ST D21S11: 29,33.2
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 11
ST D8S1179: 10,13
ST FGA: 21,22
ST Penta D: 9,13
ST Penta E: 16
ST TH01: 7,9 (ATCC; Cosmic-CLP)
ST TH01: 7,9,9.1 (PubMed=25877200)
ST TPOX: 8
ST vWA: 18
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2028
AC CVCL_A522
SY H2028; H-2028
DR Cosmic; 1518104
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2646 ! NCI-BL2028
SX Male
CA Cancer cell line
//
ID NCI-H2029
AC CVCL_1516
SY H2029; H-2029
DR BTO; BTO:0005977
DR CLO; CLO_0008040
DR ATCC; CRL-5913
DR CCLE; NCIH2029_LUNG
DR ChEMBL-Cells; CHEMBL3308473
DR ChEMBL-Targets; CHEMBL1075529
DR Cosmic; 688011
DR Cosmic; 1995552
DR Cosmic; 2125207
DR Cosmic-CLP; 688011
DR GDSC; 688011
DR GEO; GSM887396
DR GEO; GSM888474
DR GEO; GSM1670207
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,14
ST D16S539: 12
ST D3S1358: Not_detected
ST D5S818: 10,11
ST D7S820: 9,11
ST TH01: 6,9.3 (ATCC)
ST TH01: 7,9.3 (Cosmic-CLP; PubMed=20679594)
ST TPOX: 8
ST vWA: 15,20 (ATCC)
ST vWA: 15,19 (Cosmic-CLP; PubMed=20679594)
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1513 ! NCI-H1994
SX Female
CA Cancer cell line
//
ID NCI-H2030
AC CVCL_1517
SY H2030; H-2030
DR CLO; CLO_0008041
DR EFO; EFO_0002274
DR ATCC; CRL-5914
DR BioSample; SAMN03471413
DR CCLE; NCIH2030_LUNG
DR ChEMBL-Cells; CHEMBL3308769
DR ChEMBL-Targets; CHEMBL1075530
DR Cosmic; 722045
DR Cosmic; 903611
DR Cosmic; 1146897
DR Cosmic; 1609520
DR Cosmic; 1995553
DR Cosmic-CLP; 722045
DR GDSC; 722045
DR GEO; GSM206483
DR GEO; GSM434332
DR GEO; GSM784272
DR GEO; GSM794344
DR GEO; GSM887397
DR GEO; GSM888475
DR GEO; GSM1374717
DR GEO; GSM1670208
DR IGRhCellID; NCIH2030
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 12
ST D18S51: 17,18
ST D21S11: 30
ST D3S1358: 18
ST D5S818: 11
ST D7S820: 10
ST D8S1179: 11,15
ST FGA: 20,24
ST Penta D: 9
ST Penta E: 11,15
ST TH01: 9.3
ST TPOX: 9,12
ST vWA: 15
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2052
AC CVCL_1518
SY H2052; H-2052; H2052_MM; NCIH2052
DR CLO; CLO_0008042
DR EFO; EFO_0002275
DR ATCC; CRL-5915
DR BioSample; SAMN03471041
DR BioSample; SAMN03472597
DR CCLE; NCIH2052_PLEURA
DR CCRID; 3111C0001CCC000289
DR ChEMBL-Cells; CHEMBL3308119
DR ChEMBL-Targets; CHEMBL1075531
DR Cosmic; 688058
DR Cosmic; 877272
DR Cosmic; 877437
DR Cosmic; 886390
DR Cosmic; 980998
DR Cosmic; 1032389
DR Cosmic; 1146898
DR Cosmic; 1481545
DR Cosmic; 1522774
DR Cosmic; 1541213
DR Cosmic; 1571797
DR Cosmic; 1749565
DR Cosmic; 1891920
DR Cosmic; 1963327
DR Cosmic; 1995554
DR Cosmic; 2474148
DR Cosmic-CLP; 688058
DR GDSC; 688058
DR GEO; GSM434305
DR GEO; GSM726264
DR GEO; GSM794345
DR GEO; GSM887398
DR GEO; GSM888476
DR GEO; GSM1670209
DR IGRhCellID; H2052_MMGEO
DR IGRhCellID; NCIH2052
RX PubMed=8806092;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=21642991;
RX PubMed=22460905;
RX PubMed=23830731;
RX PubMed=24926545;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 48 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 11,13
ST D18S51: 17
ST D21S11: 32.2
ST D3S1358: 14,15
ST D5S818: 11
ST D7S820: 12 (ATCC; Cosmic-CLP)
ST D7S820: 11,12 (PubMed=25877200)
ST D8S1179: 13
ST FGA: 24
ST Penta D: 10
ST Penta E: 12,16
ST TH01: 7,9.3
ST TPOX: 8,11 (ATCC; Cosmic-CLP)
ST TPOX: 8 (PubMed=25877200)
ST vWA: 17
DI NCIt; C7985; Epithelioid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2647 ! NCI-BL2052
SX Male
CA Cancer cell line
//
ID NCI-H2058
AC CVCL_A523
SY H2058; H-2058
DR Cosmic; 877438
RX PubMed=8806092;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2059
AC CVCL_1519
SY H2059; H-2059
DR CLO; CLO_0008043
DR ATCC; CRL-5916
DR BioSample; SAMN03472598
DR Cosmic; 753603
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Discontinued: ATCC; CRL-5916; true.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 14
ST D16S539: 8
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 8
ST TPOX: 8,9
ST vWA: 19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1534 ! NCI-H2141
OI CVCL_2653 ! NCI-BL2141
SX Male
CA Cancer cell line
//
ID NCI-H2066
AC CVCL_1520
SY H2066; H-2066; NCIH2066
DR CLO; CLO_0008044
DR ATCC; CRL-5917
DR BioSample; SAMN03472599
DR CCLE; NCIH2066_LUNG
DR Cosmic-CLP; 1330973
DR GDSC; 1330973
DR GEO; GSM434788
DR GEO; GSM887399
DR GEO; GSM888477
DR GEO; GSM1374718
DR GEO; GSM1670210
DR KCLB; 92066
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 92066; probable.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 14
ST D13S317: 12
ST D16S539: 12,13
ST D5S818: 13
ST D7S820: 10,12
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H2073
AC CVCL_1521
SY H2073; H-2073
DR CLO; CLO_0008045
DR EFO; EFO_0006670
DR ATCC; CRL-5918
DR BioSample; SAMN03473292
DR CCLE; NCIH2073_LUNG
DR Cosmic; 687811
DR Cosmic; 903612
DR Cosmic; 1146899
DR Cosmic; 1870268
DR GEO; GSM253368
DR GEO; GSM513954
DR GEO; GSM514339
DR GEO; GSM794346
DR GEO; GSM888478
DR GEO; GSM1374719
RX PubMed=8806092;
RX PubMed=22460905;
RX PubMed=24297535;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 13
ST D16S539: 12
ST D18S51: 13,18
ST D21S11: 29
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 12
ST D8S1179: 12,14
ST FGA: 22,23
ST Penta D: 10
ST Penta E: 12
ST TH01: 6,9.3
ST TPOX: 9
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E102 ! NCI-BL1993
OI CVCL_1512 ! NCI-H1993
SX Female
CA Cancer cell line
//
ID NCI-H2077
AC CVCL_5157
SY H2077; H-2077
DR ATCC; CRL-5919
DR Cosmic; 877250
DR Cosmic; 877439
DR Cosmic; 903613
DR Cosmic; 980990
DR Cosmic; 1032462
DR GEO; GSM434269
DR GEO; GSM794347
DR IGRhCellID; H2077GEO
DR PRIDE; PXD002556
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=26361996;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep proteome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-5919; true.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E103 ! NCI-BL2077
SX Male
CA Cancer cell line
//
ID NCI-H2081
AC CVCL_1522
SY H2081; H-2081
DR CLO; CLO_0008046
DR EFO; EFO_0002276
DR ATCC; CRL-5920
DR BioSample; SAMN03472952
DR CCLE; NCIH2081_LUNG
DR ChEMBL-Cells; CHEMBL3308319
DR ChEMBL-Targets; CHEMBL2366082
DR Cosmic; 688012
DR Cosmic; 877385
DR Cosmic; 908480
DR Cosmic; 980955
DR Cosmic; 1032426
DR Cosmic; 1891915
DR Cosmic; 1995555
DR Cosmic; 2125241
DR Cosmic-CLP; 908480
DR GDSC; 908480
DR GEO; GSM827527
DR GEO; GSM887400
DR GEO; GSM888479
DR GEO; GSM1670211
DR IGRhCellID; NCIH2081
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'NCI-H2018' in Cosmic 877385.
ST Source(s): ATCC; Cosmic-CLP; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11
ST D18S51: 13,14
ST D21S11: 30
ST D3S1358: 16
ST D5S818: 10
ST D7S820: 8,10
ST D8S1179: 14,15
ST FGA: 20
ST Penta D: 12
ST Penta E: 7,12
ST TH01: 9
ST TPOX: 8
ST vWA: 16
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H2085
AC CVCL_1523
SY H2085; H-2085
DR CLO; CLO_0008047
DR ATCC; CRL-5921
DR BioSample; SAMN03472600
DR CCLE; NCIH2085_LUNG
DR Cosmic; 687812
DR Cosmic; 1995556
DR Cosmic-CLP; 687812
DR GDSC; 687812
DR GEO; GSM513955
DR GEO; GSM514340
DR GEO; GSM784273
DR GEO; GSM794348
DR GEO; GSM827509
DR GEO; GSM887401
DR GEO; GSM888480
DR GEO; GSM1374720
DR GEO; GSM1670212
RX PubMed=8806092;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 13
ST D5S818: 13
ST D7S820: 11
ST TH01: 9.3
ST TPOX: 8
ST vWA: 15,19
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2086
AC CVCL_A524
SY H2086; H-2086
DR GEO; GSM794349
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=20679594;
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12,13
ST D16S539: 13
ST D5S818: 13
ST D7S820: 11
ST TH01: 9.3
ST TPOX: 8
ST vWA: 15,19,20
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2087
AC CVCL_1524
SY H2087; H-2087
DR BTO; BTO:0003241
DR CLO; CLO_0008048
DR EFO; EFO_0002277
DR ATCC; CRL-5922
DR BioSample; SAMN03472602
DR CCLE; NCIH2087_LUNG
DR CCRID; 3111C0001CCC000253
DR ChEMBL-Cells; CHEMBL3308770
DR ChEMBL-Targets; CHEMBL1075532
DR Cosmic; 724834
DR Cosmic; 877251
DR Cosmic; 877440
DR Cosmic; 903614
DR Cosmic; 917389
DR Cosmic; 961840
DR Cosmic; 980991
DR Cosmic; 1006536
DR Cosmic; 1032463
DR Cosmic; 1146900
DR Cosmic; 1152516
DR Cosmic; 1209730
DR Cosmic; 1219085
DR Cosmic; 1239890
DR Cosmic; 1477422
DR Cosmic; 1518086
DR Cosmic; 1891900
DR Cosmic; 1925847
DR Cosmic; 1995557
DR Cosmic; 2125242
DR Cosmic-CLP; 724834
DR GDSC; 724834
DR GEO; GSM62329
DR GEO; GSM253370
DR GEO; GSM434306
DR GEO; GSM513956
DR GEO; GSM514341
DR GEO; GSM794350
DR GEO; GSM887402
DR GEO; GSM888481
DR GEO; GSM1670213
DR IGRhCellID; NCIH2087
DR KCLB; 25922
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=16157194;
RX PubMed=19472407;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/LungCellLineDescriptions/NCI-H2087.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=11416159; PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9,11
ST D18S51: 14
ST D21S11: 30,32.2
ST D3S1358: 15,17
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 10,12
ST FGA: 20
ST TH01: 7,9
ST TPOX: 11
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2648 ! NCI-BL2087
SX Male
CA Cancer cell line
//
ID NCI-H209
AC CVCL_1525
SY H209; H-209; NCIH209
DR BTO; BTO:0003020
DR CLO; CLO_0008049
DR EFO; EFO_0006671
DR ATCC; HTB-172
DR BCRC; 60123
DR BioSample; SAMN03473244
DR CCLE; NCIH209_LUNG
DR CCRID; 3111C0001CCC000045
DR ChEMBL-Cells; CHEMBL3308293
DR ChEMBL-Targets; CHEMBL2366365
DR CLS; 300183/p743_NCI-H209
DR Cosmic; 688013
DR Cosmic; 755463
DR Cosmic; 801617
DR Cosmic; 808317
DR Cosmic; 808396
DR Cosmic; 844819
DR Cosmic; 850429
DR Cosmic; 876165
DR Cosmic; 877202
DR Cosmic; 897518
DR Cosmic; 1004691
DR Cosmic; 1021855
DR Cosmic; 1219100
DR Cosmic; 1239937
DR Cosmic; 1518090
DR Cosmic; 1891903
DR Cosmic; 2125243
DR Cosmic; 2239097
DR Cosmic; 2301573
DR Cosmic-CLP; 688013
DR DSMZ; ACC-499
DR GDSC; 688013
DR GEO; GSM169438
DR GEO; GSM380511
DR GEO; GSM784248
DR GEO; GSM794276
DR GEO; GSM845543
DR GEO; GSM844636
DR GEO; GSM887403
DR GEO; GSM888482
DR GEO; GSM1374721
DR GEO; GSM1670214
DR IGRhCellID; NCIH209
DR KCB; KCB 200816YJ
DR KCLB; 30172
RX PubMed=1563005;
RX PubMed=2985257;
RX PubMed=7736387;
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=9559344;
RX PubMed=9815546;
RX PubMed=10037197;
RX PubMed=10987304;
RX PubMed=11005564;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=14762065;
RX PubMed=16157194;
RX PubMed=19472407;
RX PubMed=20016488;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://www.pawefish.path.cam.ac.uk/LungCellLineDescriptions/NCI-H209.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~50-70 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; KCLB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 9,12
ST D18S51: 13
ST D21S11: 32.2
ST D3S1358: 18
ST D5S818: 12
ST D7S820: 9
ST D8S1179: 12,13
ST FGA: 20,24
ST Penta D: 11,12
ST Penta E: 11,12
ST TH01: 7,9
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2649 ! NCI-BL209
SX Male
CA Cancer cell line
//
ID NCI-H2106
AC CVCL_1526
SY NCI H2106; H2106; H-2106
DR CLO; CLO_0008050
DR EFO; EFO_0006672
DR ATCC; CRL-5923
DR BioSample; SAMN03473266
DR CCLE; NCIH2106_LUNG
DR Cosmic; 687813
DR GEO; GSM794351
DR GEO; GSM887404
DR GEO; GSM888483
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; PubMed=20679594; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 13
ST D16S539: 12,13
ST D18S51: 14,16
ST D19S433: 13,14
ST D21S11: 30,32.2
ST D2S1338: 17,23
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 11
ST D8S1179: 13,14
ST FGA: 20
ST Penta D: 9,10
ST Penta E: 7,12
ST TH01: 9
ST TPOX: 11
ST vWA: 18,19
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2107
AC CVCL_1527
SY H2107; H-2107; NCIH2107
DR CLO; CLO_0008051
DR EFO; EFO_0002278
DR ATCC; CRL-5983
DR ATCC; CRL-5983_FL
DR BioSample; SAMN03472632
DR ChEMBL-Cells; CHEMBL3308879
DR ChEMBL-Targets; CHEMBL2366122
DR Cosmic; 877231
DR Cosmic; 877386
DR Cosmic; 924246
DR Cosmic; 980956
DR Cosmic; 1021881
DR Cosmic; 1032427
DR Cosmic; 1219107
DR Cosmic; 1239946
DR Cosmic; 1518091
DR Cosmic; 1891916
DR Cosmic; 2125208
DR GDSC; 924246
DR GEO; GSM794352
DR GEO; GSM845544
DR GEO; GSM844637
DR IGRhCellID; NCIH2107
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=19472407;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-5983; true.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12,13
ST D16S539: 10,13
ST D5S818: 14
ST D7S820: 8
ST TH01: 6,7
ST TPOX: 10,11
ST vWA: 17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2650 ! NCI-BL2107
OI CVCL_1528 ! NCI-H2108
SX Male
CA Cancer cell line
//
ID NCI-H2108
AC CVCL_1528
SY H2108; H-2108
DR CLO; CLO_0008052
DR ATCC; CRL-5984
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12,13
ST D16S539: 10,13
ST D5S818: 14
ST D7S820: 8
ST TH01: 6,7
ST TPOX: 10,11
ST vWA: 17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2650 ! NCI-BL2107
OI CVCL_1527 ! NCI-H2107
SX Male
CA Cancer cell line
//
ID NCI-H211
AC CVCL_1529
SY H211; H-211
DR BTO; BTO:0004427
DR CLO; CLO_0008053
DR ATCC; CRL-5824
DR BioSample; SAMN03473064
DR CCLE; NCIH211_LUNG
DR Cosmic; 844550
DR Cosmic; 877203
DR Cosmic; 980930
DR Cosmic; 1021856
DR Cosmic; 1032396
DR Cosmic; 1152464
DR Cosmic; 1995558
DR Cosmic-CLP; 1240189
DR GDSC; 1240189
DR GEO; GSM169440
DR GEO; GSM784209
DR GEO; GSM794277
DR GEO; GSM887406
DR GEO; GSM888485
DR GEO; GSM986171
DR GEO; GSM1670215
DR KCLB; 90211
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 90211; probable.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9
ST D16S539: 13
ST D18S51: 14
ST D21S11: 30
ST D3S1358: 18
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 12,14
ST FGA: 22
ST Penta D: 9,13
ST Penta E: 12,15
ST TH01: 6
ST TPOX: 11
ST vWA: 14,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H2110
AC CVCL_1530
SY H2110; H-2110
DR CLO; CLO_0008054
DR EFO; EFO_0006673
DR ATCC; CRL-5924
DR BioSample; SAMN03473198
DR CCLE; NCIH2110_LUNG
DR Cosmic; 1146901
DR Cosmic-CLP; 1298351
DR GDSC; 1298351
DR GEO; GSM434270
DR GEO; GSM887405
DR GEO; GSM888484
DR GEO; GSM1670216
DR IGRhCellID; H2110GEO
RX PubMed=8806092;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11
ST D18S51: 16
ST D21S11: 30
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 8,11
ST D8S1179: 14
ST FGA: 22,24
ST Penta D: 9,11
ST Penta E: 8,13
ST TH01: 9
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID NCI-H2115
AC CVCL_E104
SY H2115; H-2115
RX PubMed=8806092;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2122
AC CVCL_1531
SY H2122; H-2122; NCIH2122
DR BTO; BTO:0003006
DR CLO; CLO_0008055
DR EFO; EFO_0002279
DR ATCC; CRL-5985
DR BioSample; SAMN03473110
DR CCLE; NCIH2122_LUNG
DR ChEMBL-Cells; CHEMBL3308771
DR ChEMBL-Targets; CHEMBL1075533
DR Cosmic; 722046
DR Cosmic; 850435
DR Cosmic; 877252
DR Cosmic; 877441
DR Cosmic; 903615
DR Cosmic; 1028947
DR Cosmic; 1146902
DR Cosmic; 1152517
DR Cosmic; 1219086
DR Cosmic; 1239891
DR Cosmic; 1320182
DR Cosmic; 1518085
DR Cosmic; 1694665
DR Cosmic; 1870269
DR Cosmic; 1891901
DR Cosmic; 1995559
DR Cosmic; 2125195
DR Cosmic-CLP; 722046
DR GDSC; 722046
DR GEO; GSM62330
DR GEO; GSM206484
DR GEO; GSM253371
DR GEO; GSM434253
DR GEO; GSM513957
DR GEO; GSM514342
DR GEO; GSM784219
DR GEO; GSM794353
DR GEO; GSM827526
DR GEO; GSM887407
DR GEO; GSM888486
DR GEO; GSM1374722
DR GEO; GSM1374723
DR GEO; GSM1670217
DR IGRhCellID; NCIH2122
DR KCLB; 92122
RX PubMed=8806092;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=16157194;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=24135919;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/LungCellLineDescriptions/NCI-H2122.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 27 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10
ST D16S539: 9,12
ST D18S51: 19
ST D21S11: 33.2
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 13
ST FGA: 19,26
ST Penta D: 10,12
ST Penta E: 11,14
ST TH01: 7,9.3
ST TPOX: 9
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2651 ! NCI-BL2122
SX Female
CA Cancer cell line
//
ID NCI-H2126
AC CVCL_1532
SY H2126; H-2126
DR BTO; BTO:0003240
DR CLO; CLO_0008056
DR EFO; EFO_0002280
DR ATCC; CCL-256
DR ATCC; CRL-5925
DR BioSample; SAMN03471320
DR BioSample; SAMN03471386
DR CCLE; NCIH2126_LUNG
DR ChEMBL-Cells; CHEMBL3308894
DR ChEMBL-Targets; CHEMBL2366160
DR Cosmic; 687814
DR Cosmic; 877266
DR Cosmic; 903616
DR Cosmic; 961841
DR Cosmic; 1006537
DR Cosmic; 1146903
DR Cosmic; 1219066
DR Cosmic; 1239892
DR Cosmic; 1995560
DR Cosmic; 2125182
DR Cosmic-CLP; 687814
DR GDSC; 687814
DR GEO; GSM206485
DR GEO; GSM253405
DR GEO; GSM353228
DR GEO; GSM434271
DR GEO; GSM513958
DR GEO; GSM514343
DR GEO; GSM784235
DR GEO; GSM794354
DR GEO; GSM887408
DR GEO; GSM888487
DR GEO; GSM1374724
DR GEO; GSM1670218
DR IGRhCellID; NCIH2126
DR PRIDE; PXD002556
RX PubMed=8806092;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=14762065;
RX PubMed=16157194;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=26361996;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/LungCellLineDescriptions/NCI-H2126.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-5925; probable.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; PubMed=11416159; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12,14
ST D16S539: 12
ST D18S51: 14
ST D21S11: 29
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 8,9 (ATCC; Cosmic-CLP)
ST D7S820: 9 (PubMed=25877200)
ST D8S1179: 12
ST FGA: 26
ST Penta D: 10
ST Penta E: 7,10
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2652 ! NCI-BL2126
SX Male
CA Cancer cell line
//
ID NCI-H2127
AC CVCL_A525
SY H2127; H-2127
RX PubMed=8806092;
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2135
AC CVCL_1533
SY H2135; H-2135
DR CLO; CLO_0008057
DR EFO; EFO_0006674
DR ATCC; CRL-5926
DR BioSample; SAMN03472997
DR Cosmic-CLP; 1298352
DR GDSC; 1298352
DR GEO; GSM827510
DR GEO; GSM1374725
DR GEO; GSM1670219
RX PubMed=8806092;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 12
ST D21S11: 29
ST D3S1358: 16,17
ST D5S818: 12,13
ST D7S820: 11,12
ST D8S1179: 13,14
ST FGA: 23
ST Penta D: 8
ST Penta E: 12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID NCI-H2141
AC CVCL_1534
SY H2141; H-2141; NCIH2141
DR CLO; CLO_0008058
DR ATCC; CRL-5927
DR BioSample; SAMN03472603
DR CCLE; NCIH2141_LUNG
DR ChEMBL-Cells; CHEMBL3308556
DR ChEMBL-Targets; CHEMBL2366323
DR Cosmic; 688014
DR Cosmic; 850436
DR Cosmic; 877232
DR Cosmic; 877387
DR Cosmic; 1219108
DR Cosmic; 1239947
DR Cosmic; 2125209
DR Cosmic-CLP; 688014
DR GDSC; 688014
DR GEO; GSM794355
DR GEO; GSM844638
DR GEO; GSM887409
DR GEO; GSM888488
DR GEO; GSM1670220
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=19472407;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=20679594
ST Amelogenin: X,Y (ATCC; PubMed=20679594)
ST Amelogenin: X (Cosmic-CLP)
ST CSF1PO: 11
ST D13S317: 14
ST D16S539: 8
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 6,8 (ATCC)
ST TH01: 8 (PubMed=20679594)
ST TH01: 8,9.3 (Cosmic-CLP)
ST TPOX: 8,9
ST vWA: 19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1519 ! NCI-H2059
OI CVCL_2653 ! NCI-BL2141
SX Male
CA Cancer cell line
//
ID NCI-H2145
AC CVCL_A526
SY H2145; H-2145
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H2170
AC CVCL_1535
SY H2170; H-2170; NCIH2170
DR BTO; BTO:0005425
DR CLO; CLO_0008059
DR EFO; EFO_0002281
DR ATCC; CRL-5928
DR BCRJ; 0271
DR BioSample; SAMN03471883
DR CCLE; NCIH2170_LUNG
DR CCRID; 3111C0001CCC000354
DR ChEMBL-Cells; CHEMBL3308460
DR ChEMBL-Targets; CHEMBL1075534
DR Cosmic; 687815
DR Cosmic; 1802304
DR Cosmic; 1995561
DR Cosmic; 2042870
DR Cosmic; 2060537
DR Cosmic; 2125196
DR Cosmic-CLP; 687815
DR GDSC; 687815
DR GEO; GSM62966
DR GEO; GSM434789
DR GEO; GSM784214
DR GEO; GSM794356
DR GEO; GSM827511
DR GEO; GSM844639
DR GEO; GSM887410
DR GEO; GSM888489
DR GEO; GSM1670221
DR IGRhCellID; NCIH2170
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9
ST D16S539: 12,14
ST D18S51: 13,14
ST D21S11: 31.2
ST D3S1358: 19
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 14
ST FGA: 25,26
ST Penta D: 9
ST Penta E: 7,13
ST TH01: 8,9.3
ST TPOX: 8,9
ST vWA: 15,19
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2171
AC CVCL_1536
SY H2171; H-2171; NCIH2171
DR BTO; BTO:0005978
DR CLO; CLO_0008060
DR EFO; EFO_0002282
DR ATCC; CRL-5929
DR BioSample; SAMN03471007
DR CCLE; NCIH2171_LUNG
DR ChEMBL-Cells; CHEMBL3308320
DR ChEMBL-Targets; CHEMBL2366213
DR Cosmic; 688015
DR Cosmic; 850437
DR Cosmic; 877233
DR Cosmic; 877388
DR Cosmic; 980957
DR Cosmic; 1021882
DR Cosmic; 1032428
DR Cosmic; 1219109
DR Cosmic; 1239948
DR Cosmic; 1518087
DR Cosmic; 1759280
DR Cosmic; 1891917
DR Cosmic; 1995562
DR Cosmic; 2125197
DR Cosmic-CLP; 688015
DR DSMZ; ACC-544
DR GDSC; 688015
DR GEO; GSM794357
DR GEO; GSM827525
DR GEO; GSM887411
DR GEO; GSM888490
DR GEO; GSM1670222
DR IGRhCellID; NCIH2171
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=14762065;
RX PubMed=16157194;
RX PubMed=19472407;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
WW http://www.pawefish.path.cam.ac.uk/LungCellLineDescriptions/NCI-H2171.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 40 hours (PubMed=25984343); ~35-60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=20679594; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12,13
ST D18S51: 18,21
ST D21S11: 28,32.2
ST D3S1358: 15
ST D5S818: 13
ST D7S820: 11,13
ST D8S1179: 12
ST FGA: 22
ST Penta D: 12
ST Penta E: 10
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2654 ! NCI-BL2171
SX Male
CA Cancer cell line
//
ID NCI-H2172
AC CVCL_1537
SY H2172; H-2172
DR CLO; CLO_0008061
DR EFO; EFO_0006675
DR ATCC; CRL-5930
DR BioSample; SAMN03473020
DR CCLE; NCIH2172_LUNG
DR Cosmic; 1146904
DR Cosmic-CLP; 1298353
DR GDSC; 1298353
DR GEO; GSM434294
DR GEO; GSM794358
DR GEO; GSM827524
DR GEO; GSM887412
DR GEO; GSM888491
DR GEO; GSM1374726
DR GEO; GSM1670223
DR IGRhCellID; H2172GEO
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11
ST D18S51: 15
ST D21S11: 27
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 9,12
ST D8S1179: 12,13
ST FGA: 19,22
ST Penta D: 2.2,8
ST Penta E: 7,13
ST TH01: 7
ST TPOX: 8,11
ST vWA: 15
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H2195
AC CVCL_1538
SY H2195; H-2195
DR CLO; CLO_0008062
DR EFO; EFO_0002283
DR ATCC; CRL-5931
DR Cosmic; 877389
DR Cosmic; 1219110
DR Cosmic; 1239949
DR Cosmic; 1518088
DR Cosmic; 2125244
DR GEO; GSM794359
DR IGRhCellID; NCIH2195
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10987304;
RX PubMed=11314036;
RX PubMed=19472407;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 10
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2655 ! NCI-BL2195
OI CVCL_1539 ! NCI-H2196
OI CVCL_1540 ! NCI-H2198
SX Male
CA Cancer cell line
//
ID NCI-H2196
AC CVCL_1539
SY H2196; H-2196
DR CLO; CLO_0008063
DR EFO; EFO_0006676
DR ATCC; CRL-5932
DR BioSample; SAMN03473226
DR CCLE; NCIH2196_LUNG
DR ChEMBL-Cells; CHEMBL3308772
DR ChEMBL-Targets; CHEMBL1075535
DR Cosmic; 688016
DR Cosmic; 877390
DR Cosmic; 908481
DR Cosmic; 1995563
DR Cosmic; 2125245
DR Cosmic-CLP; 908481
DR GDSC; 908481
DR GEO; GSM827562
DR GEO; GSM887413
DR GEO; GSM888492
DR GEO; GSM1670224
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 10
ST D18S51: 13,14
ST D21S11: 30
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 13
ST FGA: 22
ST Penta D: 9,10
ST Penta E: 7
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2655 ! NCI-BL2195
OI CVCL_1538 ! NCI-H2195
OI CVCL_1540 ! NCI-H2198
SX Male
CA Cancer cell line
//
ID NCI-H2198
AC CVCL_1540
SY H2198; H-2198
DR CLO; CLO_0008064
DR EFO; EFO_0006677
DR ATCC; CRL-5933
DR BioSample; SAMN03473227
DR Cosmic; 688017
DR Cosmic; 877234
DR GEO; GSM986180
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=20679594;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; PubMed=20679594; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 10
ST D18S51: 13,14
ST D21S11: 30
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 13
ST FGA: 22
ST Penta D: 9,10
ST Penta E: 7
ST TH01: 9.3
ST TPOX: 8,9 (ATCC; PubMed=20679594)
ST TPOX: 8 (PubMed=25877200)
ST vWA: 18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2655 ! NCI-BL2195
OI CVCL_1538 ! NCI-H2195
OI CVCL_1539 ! NCI-H2196
SX Male
CA Cancer cell line
//
ID NCI-H220
AC CVCL_1541
SY H220; H-220
DR CLO; CLO_0008065
DR ATCC; CRL-5825
DR BioSample; SAMN03471745
DR GDSC; 1330974
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 10
ST D5S818: 11
ST D7S820: 10,11
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2227
AC CVCL_1542
SY H2227; H-2227
DR CLO; CLO_0008066
DR ATCC; CRL-5934
DR BioSample; SAMN03473243
DR CCLE; NCIH2227_LUNG
DR CCRID; 3111C0001CCC000254
DR ChEMBL-Cells; CHEMBL3308321
DR ChEMBL-Targets; CHEMBL2366217
DR Cosmic; 688018
DR Cosmic; 877279
DR Cosmic; 877391
DR Cosmic; 980958
DR Cosmic; 1032429
DR Cosmic; 2125246
DR Cosmic-CLP; 688018
DR GDSC; 688018
DR GEO; GSM794360
DR GEO; GSM887414
DR GEO; GSM888493
DR GEO; GSM1670225
DR KCLB; 92227
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 92227; probable.
ST Source(s): ATCC; Cosmic-CLP; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8
ST D16S539: 9
ST D18S51: 12,13
ST D21S11: 28,32.2
ST D3S1358: 18
ST D5S818: 13
ST D7S820: 10,12
ST D8S1179: 13
ST FGA: 22
ST Penta D: 8,15
ST Penta E: 7,17
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2228
AC CVCL_1543
SY H2228; H-2228
DR CLO; CLO_0008067
DR EFO; EFO_0002284
DR ATCC; CRL-5935
DR BCRJ; 0330
DR BioSample; SAMN03473167
DR CCLE; NCIH2228_LUNG
DR ChEMBL-Cells; CHEMBL3308120
DR ChEMBL-Targets; CHEMBL1075536
DR Cosmic; 687816
DR Cosmic; 897513
DR Cosmic; 903617
DR Cosmic; 930491
DR Cosmic; 1146905
DR Cosmic; 1609517
DR Cosmic; 1612226
DR Cosmic; 1995564
DR Cosmic-CLP; 687816
DR GDSC; 687816
DR GEO; GSM434317
DR GEO; GSM513959
DR GEO; GSM514344
DR GEO; GSM794361
DR GEO; GSM827512
DR GEO; GSM887415
DR GEO; GSM888494
DR GEO; GSM1374727
DR GEO; GSM1670226
DR IGRhCellID; NCIH2228
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=24675041;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'HC2228' in Cosmic 1612226.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11,13
ST D18S51: 16
ST D21S11: 28,30
ST D3S1358: 16,18
ST D5S818: 12
ST D7S820: 11
ST D8S1179: 13
ST FGA: 21,22
ST Penta D: 11,13
ST Penta E: 11,16
ST TH01: 7,8
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H2228-Luc
AC CVCL_4V13
DR JCRB; JCRB1492
DR JCRB; NIHS0726
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 12
ST D7S820: 11
ST TH01: 7,8
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1543 ! NCI-H2228
SX Female
CA Cancer cell line
//
ID NCI-H2250
AC CVCL_A527
SY H2250; H-2250
DR ATCC; CRL-5936
DR GEO; GSM794362
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-5936; true.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2258
AC CVCL_A528
SY H2258; H-2258
DR Cosmic; 877442
DR Cosmic; 980959
DR Cosmic; 1032430
DR GEO; GSM794363
RX PubMed=8806092;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H226
AC CVCL_1544
SY NCI.H226; H226; H-226; HUT-226; HUT 226; NCIH226
DR BTO; BTO:0003008
DR CLO; CLO_0008068
DR EFO; EFO_0002285
DR ATCC; CRL-5826
DR BioSample; SAMN03471987
DR CCLE; NCIH226_LUNG
DR CCRID; 3131C0001001200016
DR ChEMBL-Cells; CHEMBL3307697
DR ChEMBL-Targets; CHEMBL614740
DR Cosmic; 733816
DR Cosmic; 875850
DR Cosmic; 877259
DR Cosmic; 877402
DR Cosmic; 886388
DR Cosmic; 903570
DR Cosmic; 905941
DR Cosmic; 931374
DR Cosmic; 974291
DR Cosmic; 980961
DR Cosmic; 1006539
DR Cosmic; 1028953
DR Cosmic; 1032433
DR Cosmic; 1047100
DR Cosmic; 1092618
DR Cosmic; 1152497
DR Cosmic; 1175863
DR Cosmic; 1188585
DR Cosmic; 1219111
DR Cosmic; 1239951
DR Cosmic; 1305346
DR Cosmic; 1312331
DR Cosmic; 1436011
DR Cosmic; 1481544
DR Cosmic; 1802319
DR Cosmic; 1870270
DR Cosmic; 1963326
DR Cosmic; 1995565
DR Cosmic; 1998460
DR Cosmic; 2060522
DR Cosmic-CLP; 905941
DR ENCODE; ENCBS328RVB
DR ENCODE; ENCBS986NWY
DR GDSC; 905941
DR GEO; GSM50213
DR GEO; GSM50276
DR GEO; GSM62965
DR GEO; GSM206486
DR GEO; GSM750820
DR GEO; GSM794278
DR GEO; GSM799340
DR GEO; GSM799403
DR GEO; GSM847074
DR GEO; GSM844641
DR GEO; GSM844640
DR GEO; GSM844642
DR GEO; GSM887416
DR GEO; GSM888495
DR GEO; GSM1153411
DR GEO; GSM1181351
DR GEO; GSM1374728
DR GEO; GSM1374729
DR GEO; GSM1374730
DR GEO; GSM1670227
DR IGRhCellID; NCIH226
DR KCLB; 90226
DR SKY/M-FISH/CGH; 2802
RX PubMed=2041050;
RX PubMed=2386953;
RX PubMed=8806092;
RX PubMed=8806101;
RX PubMed=8956792;
RX PubMed=9649128;
RX PubMed=11030152;
RX PubMed=11369051;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=19472407;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=10
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 61 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 90226; probable.
ST Source(s): ATCC; Cosmic-CLP; PubMed=19372543; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 13,14
ST D16S539: 9,12
ST D18S51: 16
ST D19S433: 15
ST D21S11: 29,32.2
ST D2S1338: 25
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 14,15
ST FGA: 20,23
ST Penta D: 9,10
ST Penta E: 12,15
ST TH01: 8,9.3
ST TPOX: 8,11 (ATCC; Cosmic-CLP; PubMed=25877200)
ST TPOX: 8 (PubMed=19372543)
ST vWA: 17
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H226Br
AC CVCL_AX73
SY H226Br; 226Br
DR BTO; BTO:0000171
RX PubMed=7634243;
RX PubMed=8956792;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1544 ! NCI-H226
SX Male
CA Cancer cell line
//
ID NCI-H2279
AC CVCL_9642
SY H2279; H-2279
DR EFO; EFO_0003120
DR Cosmic; 1028939
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2280
AC CVCL_S142
SY H2280; H-2280
DR ATCC; CRL-5937
DR BioSample; SAMN03472604
CC Discontinued: ATCC; CRL-5937; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 11,12
ST vWA: 15,19
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H2282
AC CVCL_9643
SY H2282; H-2282
DR EFO; EFO_0003121
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2284
AC CVCL_A529
SY H2284; H-2284
RX PubMed=8806092;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H2286
AC CVCL_1545
SY H2286; H-2286; NCIH2286
DR CLO; CLO_0008069
DR ATCC; CRL-5938
DR CCLE; NCIH2286_LUNG
DR Cosmic; 980992
DR Cosmic; 1032464
DR GDSC; 1298355
DR GEO; GSM434790
DR GEO; GSM827513
DR GEO; GSM887417
DR GEO; GSM888496
DR GEO; GSM1374731
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 11,12
ST vWA: 15,19
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H2287
AC CVCL_9644
SY H2287; H-2287
DR EFO; EFO_0003122
RX PubMed=8806092;
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2291
AC CVCL_1546
SY H2291; H-2291
DR CLO; CLO_0008070
DR ATCC; CRL-5939
DR BioSample; SAMN03472605
DR CCLE; NCIH2291_LUNG
DR ChEMBL-Cells; CHEMBL3308880
DR ChEMBL-Targets; CHEMBL2366197
DR Cosmic; 724874
DR Cosmic; 903618
DR Cosmic; 1995566
DR Cosmic; 2125247
DR Cosmic-CLP; 724874
DR GDSC; 724874
DR GEO; GSM513960
DR GEO; GSM514345
DR GEO; GSM794364
DR GEO; GSM887418
DR GEO; GSM888497
DR GEO; GSM1374732
DR GEO; GSM1670228
RX PubMed=8806092;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 9,12
ST D5S818: 12
ST D7S820: 9,11
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 14
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H23
AC CVCL_1547
SY NCI.H23; H23; H-23; NCIH23
DR BTO; BTO:0003238
DR CLO; CLO_0008071
DR EFO; EFO_0002286
DR ATCC; CRL-5800
DR BioSample; SAMN03471316
DR BioSample; SAMN03471735
DR CCLE; NCIH23_LUNG
DR CCRID; 3111C0001CCC000255
DR ChEMBL-Cells; CHEMBL3307750
DR ChEMBL-Targets; CHEMBL614997
DR Cosmic; 687818
DR Cosmic; 722038
DR Cosmic; 801587
DR Cosmic; 844829
DR Cosmic; 852004
DR Cosmic; 875849
DR Cosmic; 876142
DR Cosmic; 877237
DR Cosmic; 905942
DR Cosmic; 910561
DR Cosmic; 914948
DR Cosmic; 917993
DR Cosmic; 953983
DR Cosmic; 961834
DR Cosmic; 974292
DR Cosmic; 1004697
DR Cosmic; 1089217
DR Cosmic; 1092619
DR Cosmic; 1146906
DR Cosmic; 1154591
DR Cosmic; 1175864
DR Cosmic; 1188590
DR Cosmic; 1219060
DR Cosmic; 1239881
DR Cosmic; 1305347
DR Cosmic; 1312332
DR Cosmic; 1436010
DR Cosmic; 1802313
DR Cosmic; 1870271
DR Cosmic; 1995567
DR Cosmic; 1998461
DR Cosmic; 2125183
DR Cosmic; 2433751
DR Cosmic-CLP; 905942
DR GDSC; 905942
DR GEO; GSM50214
DR GEO; GSM50277
DR GEO; GSM206487
DR GEO; GSM253310
DR GEO; GSM353232
DR GEO; GSM385519
DR GEO; GSM385530
DR GEO; GSM434335
DR GEO; GSM482108
DR GEO; GSM513961
DR GEO; GSM514346
DR GEO; GSM750803
DR GEO; GSM794267
DR GEO; GSM799341
DR GEO; GSM799404
DR GEO; GSM827478
DR GEO; GSM847075
DR GEO; GSM844643
DR GEO; GSM887421
DR GEO; GSM888500
DR GEO; GSM1153412
DR GEO; GSM1181268
DR GEO; GSM1181312
DR GEO; GSM1374733
DR GEO; GSM1374734
DR GEO; GSM1374735
DR GEO; GSM1670229
DR IGRhCellID; NCIH23
DR KCLB; 90023
DR SKY/M-FISH/CGH; 2796
RX PubMed=2041050;
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=11005564;
RX PubMed=11030152;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=19472407;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=23381221;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24135919;
RX PubMed=25120651;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=6
WW http://www.addexbio.com/productdetail?pid=4861
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-401.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 35 hours (PubMed=25984343); 33.4 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'H23' in PubMed=23381221 and PubMed=25120651 (confirmed by author personal communication).
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=19372543; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 11 (ATCC)
ST D16S539: 9,11 (Cosmic-CLP; PubMed=19372543; PubMed=25877200)
ST D18S51: 14,16
ST D19S433: 12,14
ST D21S11: 30
ST D2S1338: 18,23
ST D3S1358: 15
ST D5S818: 12,13 (ATCC; Cosmic-CLP; KCLB; PubMed=19372543)
ST D5S818: 12 (PubMed=25877200)
ST D7S820: 9,10
ST D8S1179: 15
ST FGA: 24
ST Penta D: 8
ST Penta E: 7,17
ST TH01: 6
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H23-Luc
AC CVCL_4W97
DR JCRB; JCRB1509
DR JCRB; NIHS0727
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 11
ST D5S818: 12,13
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1547 ! NCI-H23
SX Male
CA Cancer cell line
//
ID NCI-H2330
AC CVCL_1548
SY H2330; H-2330
DR CLO; CLO_0008072
DR ATCC; CRL-5940
DR BioSample; SAMN03472606
DR Cosmic; 688019
DR GEO; GSM827444
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 9
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 9,10
ST TH01: 9.3
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H2332
AC CVCL_A530
SY H2332; H-2332
DR Cosmic; 1021883
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2342
AC CVCL_1549
SY H2342; H-2342
DR CLO; CLO_0008073
DR ATCC; CRL-5941
DR BioSample; SAMN03472998
DR CCLE; NCIH2342_LUNG
DR ChEMBL-Cells; CHEMBL3308773
DR ChEMBL-Targets; CHEMBL1075537
DR Cosmic; 687819
DR Cosmic; 903619
DR Cosmic; 1609514
DR Cosmic; 1995568
DR Cosmic-CLP; 687819
DR GDSC; 687819
DR GEO; GSM513962
DR GEO; GSM514347
DR GEO; GSM794365
DR GEO; GSM827408
DR GEO; GSM887419
DR GEO; GSM888498
DR GEO; GSM1374736
DR GEO; GSM1670230
RX PubMed=8806092;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 13
ST D18S51: 17
ST D21S11: 31.2,32
ST D3S1358: 14
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 14,15
ST FGA: 20
ST Penta D: 12
ST Penta E: 5
ST TH01: 9,9.3
ST TPOX: 8,10
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2347
AC CVCL_1550
SY H2347; H-2347; NCIH2347
DR BTO; BTO:0005293
DR CLO; CLO_0008074
DR EFO; EFO_0002287
DR ATCC; CRL-5942
DR BioSample; SAMN03472999
DR CCLE; NCIH2347_LUNG
DR ChEMBL-Cells; CHEMBL3308386
DR ChEMBL-Targets; CHEMBL1075538
DR Cosmic; 687820
DR Cosmic; 877253
DR Cosmic; 903620
DR Cosmic; 914950
DR Cosmic; 1146907
DR Cosmic; 1239893
DR Cosmic; 1925843
DR Cosmic; 2125248
DR Cosmic-CLP; 687820
DR GDSC; 687820
DR GEO; GSM62332
DR GEO; GSM253354
DR GEO; GSM303896
DR GEO; GSM337707
DR GEO; GSM434254
DR GEO; GSM513963
DR GEO; GSM514348
DR GEO; GSM784201
DR GEO; GSM794366
DR GEO; GSM827514
DR GEO; GSM844644
DR GEO; GSM887420
DR GEO; GSM888499
DR GEO; GSM1374737
DR GEO; GSM1670231
DR IGRhCellID; NCIH2347
RX PubMed=8806092;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12,14
ST D16S539: 11
ST D18S51: 12,19
ST D21S11: 31,31.2
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 10,13
ST FGA: 20,25
ST Penta D: 12
ST Penta E: 8,19
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,19
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2656 ! NCI-BL2347
SX Female
CA Cancer cell line
//
ID NCI-H2365
AC CVCL_A531
SY H2365; H-2365
RX PubMed=8806092;
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2369
AC CVCL_A532
SY H2369; H-2369
DR EFO; EFO_0006678
DR BioSample; SAMN03471012
DR Cosmic; 1995411
DR Cosmic-CLP; 1290808
DR GDSC; 1290808
DR GEO; GSM1669818
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=23830731;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 13
ST D18S51: 13,15
ST D21S11: 29
ST D3S1358: 16
ST D5S818: 10,12
ST D7S820: 10
ST D8S1179: 11,13
ST FGA: 19,21
ST Penta D: 14
ST Penta E: 7,13
ST TH01: 9
ST TPOX: 8
ST vWA: 17
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2373
AC CVCL_A533
SY H2373; H-2373
DR EFO; EFO_0006679
DR ATCC; CRL-5943
DR BioSample; SAMN03471008
DR BioSample; SAMN03472607
DR Cosmic; 886391
DR Cosmic; 1032375
DR Cosmic; 1522781
DR Cosmic; 1541217
DR Cosmic-CLP; 1290809
DR GDSC; 1290809
DR GEO; GSM726265
DR GEO; GSM1669819
RX PubMed=7695406;
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=21642991;
RX PubMed=23830731;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Discontinued: ATCC; CRL-5943; true.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,12
ST D16S539: 12
ST D18S51: 17
ST D21S11: 30
ST D3S1358: 16,18
ST D5S818: 11,13
ST D7S820: 8,11
ST D8S1179: 12,15
ST FGA: 19,22
ST Penta D: 12
ST Penta E: 5,11
ST TH01: 9.3,10
ST TPOX: 8
ST vWA: 14,18 (ATCC)
ST vWA: 14 (Cosmic-CLP; PubMed=25877200)
DI NCIt; C45655; Sarcomatoid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2380
AC CVCL_A534
SY H2380; H-2380
DR ATCC; CRL-5986
DR BioSample; SAMN03472633
RX PubMed=8626706;
RX PubMed=8806092;
CC Discontinued: ATCC; CRL-5986; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8
ST D16S539: 11
ST D5S818: 13,15
ST D7S820: 9
ST TH01: 8
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H2405
AC CVCL_1551
SY H2405; H-2405; NCIH2405
DR CLO; CLO_0008075
DR EFO; EFO_0002288
DR ATCC; CRL-5944
DR BioSample; SAMN03470822
DR CCLE; NCIH2405_LUNG
DR ChEMBL-Cells; CHEMBL3308774
DR ChEMBL-Targets; CHEMBL1075539
DR Cosmic; 687821
DR Cosmic; 1802309
DR Cosmic; 1995569
DR Cosmic-CLP; 687821
DR GDSC; 687821
DR GEO; GSM206488
DR GEO; GSM513964
DR GEO; GSM514349
DR GEO; GSM794367
DR GEO; GSM844645
DR GEO; GSM887422
DR GEO; GSM888501
DR GEO; GSM1670232
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=20679594; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 11
ST D16S539: 12
ST D18S51: 16
ST D21S11: 29,30
ST D3S1358: 11
ST D5S818: 11,12
ST D7S820: 11
ST D8S1179: 13,14
ST FGA: 18,21
ST Penta D: 9,16
ST Penta E: 12,14
ST TH01: 9
ST TPOX: 8,10
ST vWA: 16,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2409
AC CVCL_A535
SY H2409; H-2409
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2427
AC CVCL_Y288
SY H2427; H-2427
RX PubMed=11030152;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2444
AC CVCL_1552
SY H2444; H-2444
DR CLO; CLO_0008076
DR ATCC; CRL-5945
DR BioSample; SAMN03472608
DR BioSample; SAMN03473022
DR CCLE; NCIH2444_LUNG
DR Cosmic; 1146908
DR Cosmic; 1995570
DR Cosmic-CLP; 1298356
DR GDSC; 1298356
DR GEO; GSM434295
DR GEO; GSM887423
DR GEO; GSM888502
DR GEO; GSM1374738
DR GEO; GSM1670233
DR GEO; GSM1682810
DR IGRhCellID; H2444GEO
DR PRIDE; PXD002556
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=26361996;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 12
ST D18S51: 13
ST D21S11: 28,29
ST D3S1358: 14
ST D5S818: 10
ST D7S820: 8,10 (ATCC; Cosmic-CLP)
ST D7S820: 8 (PubMed=25877200)
ST D8S1179: 11,12,13
ST FGA: 25
ST Penta D: 9,12
ST Penta E: 5
ST TH01: 9.3
ST TPOX: 11
ST vWA: 17
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2452
AC CVCL_1553
SY H2452; H-2452; NCIH2452
DR CLO; CLO_0008077
DR EFO; EFO_0006680
DR ATCC; CRL-5946
DR BioSample; SAMN03471009
DR CCLE; NCIH2452_PLEURA
DR CCRID; 3131C0001001200017
DR ChEMBL-Cells; CHEMBL3308580
DR ChEMBL-Targets; CHEMBL1075540
DR Cosmic; 886392
DR Cosmic; 908462
DR Cosmic; 1032373
DR Cosmic; 1481546
DR Cosmic; 1522763
DR Cosmic; 1541212
DR Cosmic; 1571798
DR Cosmic; 1749557
DR Cosmic; 1963328
DR Cosmic; 1995571
DR Cosmic; 2474096
DR Cosmic-CLP; 908462
DR GDSC; 908462
DR GEO; GSM726266
DR GEO; GSM827515
DR GEO; GSM887424
DR GEO; GSM888503
DR GEO; GSM1670234
RX PubMed=7695406;
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=21642991;
RX PubMed=22460905;
RX PubMed=24926545;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 48 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 11,13
ST D18S51: 15
ST D21S11: 28,32.2
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 10
ST FGA: 23
ST Penta D: 9
ST Penta E: 12,15
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C9351; Pleural mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2461
AC CVCL_A536
SY H2461; H-2461
DR EFO; EFO_0006681
DR BioSample; SAMN03471038
DR Cosmic; 1032371
DR Cosmic; 1087353
DR Cosmic-CLP; 1290810
DR GDSC; 1290810
DR GEO; GSM1669820
RX PubMed=7695406;
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=23830731;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 9,12
ST D16S539: 9,11
ST D18S51: 15
ST D21S11: 30
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 11,12
ST FGA: 20,22
ST Penta D: 12
ST Penta E: 10,11
ST TH01: 6,9
ST TPOX: 8,10
ST vWA: 15,17 (Cosmic-CLP)
ST vWA: 17 (PubMed=25877200)
DI NCIt; C7985; Epithelioid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H249
AC CVCL_A537
SY H249; H-249; NCIH249
DR ATCC; CRL-5827
DR BioSample; SAMN03151645
DR BioSample; SAMN03151860
DR BioSample; SAMN03471746
DR Cosmic; 755460
DR Cosmic; 877204
DR Cosmic; 980931
DR Cosmic; 1006529
DR Cosmic; 1021857
DR Cosmic; 1032397
DR Cosmic; 2125249
DR GEO; GSM845545
DR GEO; GSM844646
DR KCLB; 90249
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=20143388;
WW http://www.atcc.org/support/faqs/4bf60/NCIH249%20ATCC%20CRL5827-1073.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a NCI-H69 derivative (PubMed=20143388).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-5827; true.
CC Discontinued: KCLB; 90249; probable.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 11
ST D5S818: 11,13
ST D7S820: 9
ST TH01: 8,9
ST TPOX: 10
ST vWA: 16,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1579 ! NCI-H69
SX Male
CA Cancer cell line
//
ID NCI-H250
AC CVCL_1554
SY H250; H-250
DR CLO; CLO_0008078
DR ATCC; CRL-5828
DR BioSample; SAMN03471747
DR ChEMBL-Cells; CHEMBL3308294
DR ChEMBL-Targets; CHEMBL2366289
DR Cosmic; 688020
DR Cosmic; 924241
DR Cosmic; 1021858
DR Cosmic-CLP; 924241
DR GDSC; 924241
DR GEO; GSM1670235
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=27397505;
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Derived from metastatic site: Brain.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 12
ST D16S539: 9,13
ST D5S818: 11
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2509
AC CVCL_A538
SY H2509; H-2509
RX PubMed=8806092;
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2527
AC CVCL_A539
SY H2527; H-2527
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2540
AC CVCL_A540
SY H2540; H-2540
RX PubMed=8806092;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H2552
AC CVCL_A541
SY H2552; H-2552
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2562
AC CVCL_X977
SY H2562; H-2562
RX PubMed=11030152;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2580
AC CVCL_A542
SY H2580; H-2580
RX PubMed=8806092;
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2591
AC CVCL_A543
SY H2591; H-2591
DR BioSample; SAMN03471042
DR Cosmic; 1032379
DR Cosmic-CLP; 1240131
DR GDSC; 1240131
DR GEO; GSM1669821
RX PubMed=7695406;
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=23830731;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,14
ST D13S317: 12
ST D16S539: 10,12
ST D18S51: 12
ST D21S11: 30,32.2
ST D3S1358: 18
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 8,14
ST FGA: 19,22
ST Penta D: 12
ST Penta E: 5,10
ST TH01: 8
ST TPOX: 8,12
ST vWA: 16,17
DI NCIt; C7985; Epithelioid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2594
AC CVCL_A544
SY H2594; H-2594
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2595
AC CVCL_A545
SY H2595; H-2595
DR EFO; EFO_0006682
DR BioSample; SAMN03471011
DR Cosmic; 1032381
DR Cosmic; 1087354
DR Cosmic-CLP; 1240132
DR GDSC; 1240132
DR GEO; GSM1669822
RX PubMed=7695406;
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=23830731;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 11,13
ST D18S51: 12,24
ST D21S11: 29,31.2
ST D3S1358: 18
ST D5S818: 13
ST D7S820: 7,9
ST D8S1179: 10,14
ST FGA: 23,25
ST Penta D: 13,14
ST Penta E: 11,13
ST TH01: 6,7
ST TPOX: 11
ST vWA: 15,16
DI NCIt; C7985; Epithelioid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2596
AC CVCL_A546
SY H2596; H-2596
DR EFO; EFO_0006683
DR BioSample; SAMN03471021
DR Cosmic; 1032390
DR Cosmic; 1087355
DR GDSC; 1240133
RX PubMed=7695406;
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=23830731;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,13
ST D16S539: 12
ST D18S51: 14
ST D21S11: 29,33.2
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 9,11
ST D8S1179: 13,16
ST FGA: 20
ST Penta D: 12,13
ST Penta E: 12
ST TH01: 6
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C45655; Sarcomatoid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2597
AC CVCL_A547
SY H2597; H-2597
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2600
AC CVCL_A548
SY H2600; H-2600
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2618
AC CVCL_A549
SY H2618; H-2618
DR Cosmic; 1032391
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2679
AC CVCL_A550
SY H2679; H-2679
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H2691
AC CVCL_A551
SY H2691; H-2691
DR BioSample; SAMN03471020
DR Cosmic; 1087356
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=23830731;
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 12,13
ST D16S539: 9,12
ST D18S51: 21
ST D21S11: 30,31
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 8,11
ST D8S1179: 13
ST FGA: 22
ST Penta D: 10,13
ST Penta E: 8,9
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C45655; Sarcomatoid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2706
AC CVCL_A552
SY H2706; H-2706
RX PubMed=8806092;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2712
AC CVCL_Y289
SY H2712; H-2712
RX PubMed=11030152;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2722
AC CVCL_U994
SY H2722; H-2722
DR EFO; EFO_0006684
DR BioSample; SAMN03471016
DR Cosmic; 1995413
DR Cosmic-CLP; 1290812
DR GDSC; 1290812
DR GEO; GSM1669823
RX PubMed=23830731;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y (Cosmic-CLP)
ST Amelogenin: X (PubMed=25877200)
ST CSF1PO: 10,11
ST D13S317: 11 (Cosmic-CLP)
ST D13S317: 7.2,11 (PubMed=25877200)
ST D16S539: 13
ST D18S51: 11,13
ST D21S11: 29,33.2
ST D3S1358: 17
ST D5S818: 9,11
ST D7S820: 10,11
ST D8S1179: 11,15
ST FGA: 23
ST Penta D: 10,13
ST Penta E: 5,19
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2731
AC CVCL_U995
SY H2731; H-2731
DR BioSample; SAMN03471019
DR Cosmic-CLP; 1240134
DR GDSC; 1240134
DR GEO; GSM1669824
RX PubMed=11030152;
RX PubMed=23830731;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,13 (Cosmic-CLP)
ST D13S317: 11 (PubMed=25877200)
ST D16S539: 13
ST D18S51: 15
ST D21S11: 30,31.2
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 8,14
ST D8S1179: 8,12
ST FGA: 21
ST Penta D: 11,12
ST Penta E: 12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C45655; Sarcomatoid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2795
AC CVCL_U996
SY H2795; H-2795
DR EFO; EFO_0006685
DR BioSample; SAMN03471022
DR Cosmic; 1995414
DR Cosmic-CLP; 1290813
DR GDSC; 1290813
DR GEO; GSM1669825
RX PubMed=23830731;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 11,13
ST D16S539: 11
ST D18S51: 11,16
ST D19S433: 15
ST D21S11: 29,30
ST D2S1338: 18,25
ST D3S1358: 14,15
ST D5S818: 9,11
ST D7S820: 10,12
ST D8S1179: 12,13
ST FGA: 23
ST Penta D: 9,13
ST Penta E: 7,13
ST TH01: 6
ST TPOX: 9,11
ST vWA: 17,19
DI NCIt; C7985; Epithelioid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H28
AC CVCL_1555
SY H28; H-28; HUT-28; HUT 28; HuT 28; HUT28; Hut28; HuT28
DR CLO; CLO_0008079
DR EFO; EFO_0006686
DR ATCC; CRL-5820
DR BioSample; SAMN03471010
DR CCLE; NCIH28_PLEURA
DR ChEMBL-Cells; CHEMBL3308775
DR ChEMBL-Targets; CHEMBL1075541
DR Cosmic; 688059
DR Cosmic; 733814
DR Cosmic; 877108
DR Cosmic; 877350
DR Cosmic; 886387
DR Cosmic; 908470
DR Cosmic; 980995
DR Cosmic; 1032386
DR Cosmic; 1146909
DR Cosmic; 1152495
DR Cosmic; 1481543
DR Cosmic; 1522766
DR Cosmic; 1541208
DR Cosmic; 1749556
DR Cosmic; 1963325
DR Cosmic; 1995572
DR Cosmic; 2474149
DR Cosmic-CLP; 908470
DR GDSC; 908470
DR GEO; GSM434272
DR GEO; GSM726267
DR GEO; GSM794268
DR GEO; GSM887425
DR GEO; GSM888504
DR GEO; GSM1670236
DR IGRhCellID; H28GEO
DR KCLB; 90028
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=21642991;
RX PubMed=22460905;
RX PubMed=23830731;
RX PubMed=24926545;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 90028; probable.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 12,13
ST D18S51: 19
ST D21S11: 29,30
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 10,12
ST FGA: 19.2,21
ST Penta D: 9,10
ST Penta E: 10,16
ST TH01: 7,9
ST TPOX: 11
ST vWA: 14,15
DI NCIt; C9351; Pleural mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2803
AC CVCL_U997
SY H2803; H-2803
DR EFO; EFO_0006687
DR BioSample; SAMN03471013
DR Cosmic; 1995415
DR Cosmic-CLP; 1240135
DR GDSC; 1240135
DR GEO; GSM1669826
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 12,13
ST D16S539: 9,12
ST D18S51: 21
ST D21S11: 30,31
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 8,11
ST D8S1179: 13
ST FGA: 22
ST Penta D: 10,13
ST Penta E: 8,9
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2804
AC CVCL_U998
SY H2804; H-2804
DR EFO; EFO_0006688
DR BioSample; SAMN03471014
DR Cosmic; 1995416
DR Cosmic-CLP; 1240136
DR GDSC; 1240136
DR GEO; GSM1669827
RX PubMed=23830731;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 10
ST D16S539: 9,11
ST D18S51: 18
ST D21S11: 28,30
ST D3S1358: 18
ST D5S818: 12
ST D7S820: 9
ST D8S1179: 13,15
ST FGA: 23
ST Penta D: 13
ST Penta E: 7,10
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 14,15
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2810
AC CVCL_U999
SY H2810; H-2810
DR EFO; EFO_0006689
DR BioSample; SAMN03471017
DR Cosmic-CLP; 1240137
DR GDSC; 1240137
DR GEO; GSM1669828
RX PubMed=23830731;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 10,11
ST D18S51: 12
ST D21S11: 29
ST D3S1358: 15,18
ST D5S818: 11
ST D7S820: 7,12
ST D8S1179: 13
ST FGA: 20,21.2
ST Penta D: 14
ST Penta E: 8,10
ST TH01: 6
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C7985; Epithelioid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2818
AC CVCL_V000
SY H2818; H-2818
DR Cosmic; 1995417
DR Cosmic-CLP; 1290814
DR GDSC; 1290814
DR GEO; GSM1669829
RX PubMed=23830731;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 9,11
ST TH01: 6,7
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C7985; Epithelioid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H285
AC CVCL_A553
SY H285; H-285
DR ATCC; CRL-5829
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Discontinued: ATCC; CRL-5829; true.
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2850
AC CVCL_Y290
SY H2850; H-2850
RX PubMed=11030152;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2869
AC CVCL_V001
SY H2869; H-2869
DR Cosmic; 1995418
DR Cosmic-CLP; 1240138
DR GDSC; 1240138
DR GEO; GSM1669830
RX PubMed=23830731;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,11
ST D16S539: 13
ST D5S818: 12,13
ST D7S820: 7,8
ST TH01: 8
ST TPOX: 8
ST vWA: 16
DI NCIt; C4282; Biphasic mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2882
AC CVCL_5158
SY H2882; H-2882
DR Cosmic; 755471
DR Cosmic; 903621
DR Cosmic; 1146910
DR GEO; GSM253402
DR GEO; GSM434255
DR GEO; GSM794368
DR IGRhCellID; H2882GEO
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=12759538;
RX PubMed=20679594;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9
ST D5S818: 11
ST D7S820: 9
ST TH01: 9.3
ST TPOX: 11
ST vWA: 16
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S844 ! NCI-BL2882
SX Female
CA Cancer cell line
//
ID NCI-H2887
AC CVCL_5159
SY H2887; H-2887
DR Cosmic; 903622
DR Cosmic; 1146911
DR GEO; GSM253355
DR GEO; GSM434256
DR GEO; GSM794369
DR IGRhCellID; H2887GEO
RX PubMed=10987304;
RX PubMed=11314036;
RX PubMed=12759538;
RX PubMed=20679594;
ST Source(s): PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11
ST D5S818: 10,11
ST D7S820: 12
ST TH01: 6,9.3
ST TPOX: 12
ST vWA: 17
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S845 ! NCI-BL2887
SX Male
CA Cancer cell line
//
ID NCI-H289
AC CVCL_A554
SY H289: H-289
DR Cosmic; 877205
DR Cosmic; 1021859
DR Cosmic; 1320183
DR GEO; GSM794279
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=20679594;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 13
ST D16S539: 9
ST D5S818: 11
ST D7S820: 8,11
ST TH01: 6,9.3
ST TPOX: 8,12
ST vWA: 17,19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E095 ! NCI-BL289
SX Female
CA Cancer cell line
//
ID NCI-H290
AC CVCL_A555
SY H290: H-290; HUT-290; Hut-290; HUT 290; HUT290
DR BioSample; SAMN03471037
DR Cosmic; 733817
DR Cosmic; 877270
DR Cosmic; 877403
DR Cosmic; 886389
DR Cosmic; 980996
DR Cosmic; 1032387
DR Cosmic; 1152498
DR Cosmic; 1995419
DR Cosmic-CLP; 1240139
DR GDSC; 1240139
DR GEO; GSM794280
DR GEO; GSM1669831
DR KCLB; 90290
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=20679594;
RX PubMed=23830731;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 90290; probable.
ST Source(s): Cosmic-CLP; PubMed=20679594; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 9,12
ST D18S51: 14,15
ST D19S433: 13,15
ST D21S11: 28,31.2
ST D2S1338: 17,19
ST D3S1358: 18
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 10,14
ST FGA: 21,22
ST Penta D: 11,12
ST Penta E: 7,11
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 14,17
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H292
AC CVCL_0455
SY H292; H-292; NCI-HUT-292; Hut292; NCIH292
DR BTO; BTO:0002418
DR CLO; CLO_0008080
DR EFO; EFO_0006690
DR MCCL; MCC:0000353
DR CLDB; cl3653
DR CLDB; cl3654
DR ATCC; CRL-1848
DR BCRC; 60372
DR BCRJ; 0187
DR BioSample; SAMN03471312
DR CCLE; NCIH292_LUNG
DR CCRID; 3111C0001CCC000233
DR CCRID; 3131C0001000700122
DR ChEMBL-Cells; CHEMBL3308637
DR ChEMBL-Targets; CHEMBL614733
DR Cosmic; 753604
DR Cosmic; 844598
DR Cosmic; 877404
DR Cosmic; 1017828
DR Cosmic; 1047099
DR Cosmic; 1152499
DR Cosmic; 1188584
DR Cosmic; 1288262
DR Cosmic; 1466803
DR Cosmic; 1519249
DR Cosmic; 1520933
DR Cosmic; 1520947
DR Cosmic; 1870272
DR Cosmic; 1995573
DR Cosmic-CLP; 753604
DR ECACC; 91091815
DR GDSC; 753604
DR GEO; GSM206489
DR GEO; GSM784237
DR GEO; GSM794281
DR GEO; GSM888505
DR GEO; GSM1670237
DR ICLC; HTL96009
DR KCB; KCB 200822YJ
DR KCLB; 21848
DR SKY/M-FISH/CGH; 2844
RX PubMed=8806092;
RX PubMed=15193437;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 21848; probable.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 9,13
ST D18S51: 16
ST D21S11: 28
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 10
ST D8S1179: 11,14
ST FGA: 22,26
ST Penta D: 9
ST Penta E: 13,15
ST TH01: 8
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C45544; Lung mucoepidermoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H2925
AC CVCL_Y291
SY H2925; H-2925
RX PubMed=11030152;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H295
AC CVCL_0456
SY H295; H-295; NCI-H-295
DR BTO; BTO:0002587
DR CLO; CLO_0008081
DR MCCL; MCC:0000502
DR ATCC; CRL-10296
DR BCRC; 60354
DR BioSample; SAMN03471298
DR Cosmic; 684682
DR Cosmic; 908466
DR Cosmic; 1179076
DR Cosmic; 2239455
DR Cosmic; 2364100
DR TOKU-E; 2687
DR Wikidata; Q28226675
RX PubMed=2386954;
RX PubMed=8056157;
RX PubMed=8404594;
RX PubMed=8806089;
RX PubMed=8806092;
RX PubMed=15541570;
RX PubMed=21924324;
RX PubMed=22266826;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-402.html
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 11
ST D5S818: 12
ST D7S820: 9,12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C9325; Adrenal cortex carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H295A
AC CVCL_0457
SY H295A; H-295A
DR BTO; BTO:0005669
DR MCCL; MCC:0000354
RX PubMed=9024219;
RX PubMed=15541570;
RX PubMed=18000308;
RX PubMed=21924324;
RX PubMed=22266826;
DI NCIt; C9325; Adrenal cortex carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0456 ! NCI-H295
SX Female
CA Cancer cell line
//
ID NCI-H295R
AC CVCL_0458
SY H295R; H-295R; H295R-S1
DR BTO; BTO:0002588
DR CLO; CLO_0008082
DR EFO; EFO_0002289
DR MCCL; MCC:0000355
DR ATCC; CRL-2128
DR CCRID; 3111C0001CCC000256
DR ChEMBL-Cells; CHEMBL3307998
DR ChEMBL-Targets; CHEMBL612593
DR CLS; 300483/p789_NCI-H295R
DR Cosmic; 1172633
DR Cosmic; 1191070
DR Cosmic; 1622873
DR Cosmic; 2364101
DR Cosmic; 2574494
DR IGRhCellID; NCIH295R
DR Wikidata; Q25323725
RX PubMed=15541570;
RX PubMed=18000308;
RX PubMed=21924324;
RX PubMed=22266826;
RX PubMed=23951072;
WW https://en.wikipedia.org/wiki/H295R
ST Source(s): ATCC; CLS
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 11
ST D18S51: 17
ST D21S11: 32.2
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 9,12
ST D8S1179: 13
ST FGA: 19.2,24
ST Penta D: 8
ST Penta E: 5,12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C9325; Adrenal cortex carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0456 ! NCI-H295
SX Female
CA Cancer cell line
//
ID NCI-H295R-S2
AC CVCL_S901
SY H295R-S2
RX PubMed=21924324;
RX PubMed=22266826;
DI NCIt; C9325; Adrenal cortex carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0456 ! NCI-H295
SX Female
CA Cancer cell line
//
ID NCI-H295R-S3
AC CVCL_S902
SY H295R-S3
RX PubMed=21924324;
RX PubMed=22266826;
DI NCIt; C9325; Adrenal cortex carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0456 ! NCI-H295
SX Female
CA Cancer cell line
//
ID NCI-H2973
AC CVCL_E105
SY H2973; H-2973
RX PubMed=11030152;
RX PubMed=12759538;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H298
AC CVCL_A556
SY H298; H-298
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H3026
AC CVCL_Y292
SY H3026; H-3026
RX PubMed=11030152;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H3030
AC CVCL_Y293
SY H3030; H-3030
RX PubMed=11030152;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H3072
AC CVCL_Y294
SY H3072; H-3072
RX PubMed=11030152;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H3118
AC CVCL_A464
SY H3118; H-3118
DR Cosmic; 1288269
DR Cosmic; 1519250
DR Cosmic-CLP; 1240140
DR GDSC; 1240140
DR GEO; GSM1669832
DR SKY/M-FISH/CGH; 2845
RX PubMed=11030152;
RX PubMed=15193437;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12,14
ST D16S539: 12
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 8,12
ST vWA: 17
DI NCIt; C5938; Parotid gland mucoepidermoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H3122
AC CVCL_5160
SY H3122; H-3122; NCIH3122
DR Cosmic; 755472
DR Cosmic; 914951
DR Cosmic; 1146912
DR Cosmic; 2245571
DR Cosmic-CLP; 1240190
DR GDSC; 1240190
DR GEO; GSM253349
DR GEO; GSM434307
DR GEO; GSM794370
DR GEO; GSM1374739
DR GEO; GSM1374740
DR GEO; GSM1670238
DR IGRhCellID; H3122GEO
DR PRIDE; PXD002556
RX PubMed=11030152;
RX PubMed=12759538;
RX PubMed=20679594;
RX PubMed=24675041;
RX PubMed=26361996;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=20679594;
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,12
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7,9.3
ST TPOX: 10
ST vWA: 16
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H3123
AC CVCL_Y295
SY H3123; H-3123
RX PubMed=11030152;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H3166
AC CVCL_X979
SY H3166; H-3166
RX PubMed=11030152;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H3211
AC CVCL_X978
SY H3211; H-3211
RX PubMed=11030152;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H322
AC CVCL_1556
SY H322; H-322; H322T; NCI-H322T; NCI-322
DR BTO; BTO:0003007
DR CLO; CLO_0008083
DR EFO; EFO_0006691
DR CLDB; cl3655
DR ATCC; CRL-5806
DR BioSample; SAMN03471699
DR BioSample; SAMN03471740
DR BioSample; SAMN03473287
DR CCLE; NCIH322_LUNG
DR ChEMBL-Cells; CHEMBL3307405
DR ChEMBL-Targets; CHEMBL614573
DR Cosmic; 687822
DR Cosmic; 801589
DR Cosmic; 844830
DR Cosmic; 876143
DR Cosmic; 903571
DR Cosmic; 917976
DR Cosmic; 929972
DR Cosmic; 932922
DR Cosmic; 934547
DR Cosmic; 980962
DR Cosmic; 1028935
DR Cosmic; 1032434
DR Cosmic; 1146913
DR Cosmic; 1152500
DR Cosmic; 1239903
DR Cosmic; 1802317
DR Cosmic; 1870261
DR Cosmic; 1891884
DR Cosmic; 2042867
DR Cosmic; 2125250
DR ECACC; 95111734
DR GEO; GSM206490
DR GEO; GSM253358
DR GEO; GSM434333
DR GEO; GSM784245
DR GEO; GSM794282
DR GEO; GSM827434
DR GEO; GSM887426
DR GEO; GSM888506
DR GEO; GSM1374741
DR IGRhCellID; NCIH322
DR KCLB; 90322
RX PubMed=2386953;
RX PubMed=8806092;
RX PubMed=11005564;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Caution: We are not certain that NCI-H322 and NCI-H322M are identical.
CC Discontinued: ATCC; CRL-5806; true.
CC Discontinued: KCLB; 90322; probable.
ST Source(s): ATCC; ECACC; PubMed=11416159; PubMed=20679594; PubMed=25877200
ST Amelogenin: X,Y (ATCC; ECACC; PubMed=11416159; PubMed=20679594)
ST Amelogenin: X (PubMed=25877200)
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 17
ST D21S11: 28
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 12,15
ST FGA: 22
ST Penta D: 10
ST Penta E: 7
ST TH01: 7
ST TPOX: 8
ST vWA: 17
DI NCIt; C2923; Bronchioloalveolar carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H322M
AC CVCL_1557
SY NCI.H322M; H322M; H-322M
DR BTO; BTO:0004182
DR ChEMBL-Cells; CHEMBL3307710
DR ChEMBL-Targets; CHEMBL614803
DR Cosmic; 875851
DR Cosmic; 905967
DR Cosmic; 974293
DR Cosmic; 1092620
DR Cosmic; 1175865
DR Cosmic; 1305348
DR Cosmic; 1312333
DR Cosmic; 1995574
DR Cosmic; 1998462
DR Cosmic-CLP; 905967
DR GDSC; 905967
DR GEO; GSM50215
DR GEO; GSM50278
DR GEO; GSM434296
DR GEO; GSM750802
DR GEO; GSM799342
DR GEO; GSM799405
DR GEO; GSM1153413
DR GEO; GSM1181269
DR GEO; GSM1181316
DR GEO; GSM1374742
DR GEO; GSM1670239
DR IGRhCellID; H322M_03GEO
DR SKY/M-FISH/CGH; 2797
RX PubMed=2041050;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=11
WW http://tcpaportal.org/mclp/
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 35.3 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
CC Caution: We are not certain that NCI-H322 and NCI-H322M are identical.
ST Source(s): Cosmic-CLP; PubMed=19372543
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 17
ST D19S433: 14
ST D21S11: 28
ST D2S1338: 19,25
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 12,15
ST FGA: 22
ST TH01: 7
ST TPOX: 8
ST vWA: 17
DI NCIt; C2923; Bronchioloalveolar carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1556 ! NCI-H322
SX Male
CA Cancer cell line
//
ID NCI-H324
AC CVCL_3953
SY H324; H-324
DR BTO; BTO:0003005
DR Cosmic; 844594
DR Cosmic; 877238
DR Cosmic; 877406
DR Cosmic; 903572
DR Cosmic; 1152501
DR Cosmic; 1891885
DR GEO; GSM794283
RX PubMed=8806092;
RX PubMed=20679594;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H3255
AC CVCL_6831
SY H3255; H-3255; H3255_DA
DR EFO; EFO_0003123
DR ATCC; CRL-2882
DR BioSample; SAMN03471808
DR CCLE; NCIH3255_LUNG
DR Cosmic; 897734
DR Cosmic; 903623
DR Cosmic; 914952
DR Cosmic; 1028937
DR Cosmic; 1128245
DR Cosmic; 1146914
DR Cosmic-CLP; 1247873
DR GDSC; 1247873
DR GEO; GSM63349
DR GEO; GSM253411
DR GEO; GSM434297
DR GEO; GSM794371
DR GEO; GSM827356
DR GEO; GSM1374743
DR GEO; GSM1669833
DR IGRhCellID; H3255_DAGEO
DR PRIDE; PXD002224
DR PRIDE; PXD002556
RX PubMed=11030152;
RX PubMed=12759538;
RX PubMed=20679594;
RX PubMed=26202522;
RX PubMed=26361996;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep membrane proteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-2882; true.
ST Source(s): ATCC; Cosmic-CLP; PubMed=20679594;
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 11,13
ST D16S539: 8
ST D5S818: 11,12
ST D7S820: 10,13
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H3255DR
AC CVCL_DI56
SY H3255DR
RX PubMed=20118985;
CC Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DI55 ! NCI-H3255GR
SX Female
CA Cancer cell line
//
ID NCI-H3255GR
AC CVCL_DI55
SY H3255GR; H3255 GR
DR Cosmic; 1128246
RX PubMed=16906227;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6831 ! NCI-H3255
SX Female
CA Cancer cell line
//
ID NCI-H3282
AC CVCL_X980
SY H3282; H-3282
RX PubMed=11030152;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H345
AC CVCL_1558
SY H345; H-345; NCI H345; NCIH345
DR BTO; BTO:0003019
DR CLO; CLO_0008084
DR EFO; EFO_0006692
DR ATCC; HTB-180
DR BioSample; SAMN03471018
DR BioSample; SAMN03472734
DR ChEMBL-Cells; CHEMBL3307324
DR ChEMBL-Targets; CHEMBL614195
DR Cosmic; 688021
DR Cosmic; 755464
DR Cosmic; 844551
DR Cosmic; 850440
DR Cosmic; 877206
DR Cosmic; 877355
DR Cosmic; 1006525
DR Cosmic; 1021860
DR Cosmic; 1152465
DR Cosmic; 1219101
DR Cosmic; 1239938
DR Cosmic; 2125251
DR Cosmic-CLP; 688021
DR GDSC; 688021
DR GEO; GSM169441
DR GEO; GSM380512
DR GEO; GSM784200
DR GEO; GSM794284
DR GEO; GSM844647
DR GEO; GSM1670240
RX PubMed=1563005;
RX PubMed=2985257;
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10037197;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 8
ST D18S51: 12,13
ST D21S11: 29,31
ST D3S1358: 18
ST D5S818: 11,12 (ATCC; Cosmic-CLP)
ST D5S818: 12 (PubMed=25877200)
ST D7S820: 9,13
ST D8S1179: 14,16
ST FGA: 20
ST Penta D: 12,13
ST Penta E: 14
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 15,16
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H358
AC CVCL_1559
SY H358; H-358; NCIH358
DR BTO; BTO:0002835
DR CLO; CLO_0008085
DR EFO; EFO_0002291
DR CLDB; cl3656
DR ATCC; CRL-5807
DR BioSample; SAMN03471313
DR CCLE; NCIH358_LUNG
DR CCRID; 3131C0001000700151
DR ChEMBL-Cells; CHEMBL3307543
DR ChEMBL-Targets; CHEMBL614135
DR Cosmic; 722039
DR Cosmic; 724875
DR Cosmic; 877106
DR Cosmic; 903573
DR Cosmic; 908465
DR Cosmic; 910563
DR Cosmic; 914944
DR Cosmic; 929970
DR Cosmic; 934545
DR Cosmic; 980963
DR Cosmic; 1004699
DR Cosmic; 1028934
DR Cosmic; 1032435
DR Cosmic; 1052333
DR Cosmic; 1146915
DR Cosmic; 1219075
DR Cosmic; 1239902
DR Cosmic; 1600603
DR Cosmic; 1741780
DR Cosmic; 1802307
DR Cosmic; 1870273
DR Cosmic; 1995575
DR Cosmic; 2042868
DR Cosmic-CLP; 908465
DR ECACC; 95111733
DR GDSC; 908465
DR GEO; GSM206491
DR GEO; GSM253398
DR GEO; GSM385520
DR GEO; GSM385531
DR GEO; GSM434257
DR GEO; GSM513937
DR GEO; GSM514321
DR GEO; GSM784251
DR GEO; GSM794285
DR GEO; GSM827468
DR GEO; GSM844648
DR GEO; GSM887427
DR GEO; GSM888507
DR GEO; GSM1374744
DR GEO; GSM1670241
DR IGRhCellID; NCIH358
DR KCLB; 25807
DR KCLB; 90358
RX PubMed=2386953;
RX PubMed=8806092;
RX PubMed=8806101;
RX PubMed=9649128;
RX PubMed=11030152;
RX PubMed=11369051;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=24135919;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-368.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 38 hours (ECACC).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 12,13
ST D18S51: 14
ST D21S11: 28,30
ST D3S1358: 14,18
ST D5S818: 10,12
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 20,21
ST Penta D: 10,13
ST Penta E: 18
ST TH01: 6
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C2923; Bronchioloalveolar carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H360
AC CVCL_A557
SY H360; H-360
DR Cosmic; 1152466
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H369
AC CVCL_A558
SY H369; H-369
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H372
AC CVCL_A559
SY H372; H-372
DR Cosmic; 844552
DR Cosmic; 1152467
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H378
AC CVCL_1560
SY H378; H-378; NCIH378
DR CLO; CLO_0008086
DR ATCC; CRL-5808
DR BioSample; SAMN03471741
DR ChEMBL-Cells; CHEMBL3308295
DR ChEMBL-Targets; CHEMBL2366088
DR Cosmic; 688022
DR Cosmic; 850428
DR Cosmic; 877207
DR Cosmic; 877356
DR Cosmic; 980932
DR Cosmic; 1021861
DR Cosmic; 1032398
DR Cosmic; 1152468
DR Cosmic; 1995576
DR Cosmic-CLP; 688022
DR GDSC; 688022
DR GEO; GSM794286
DR GEO; GSM845546
DR GEO; GSM844649
DR GEO; GSM1670242
DR IGRhCellID; NCIH378
DR KCLB; 90378
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10037197;
RX PubMed=11030152;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 12
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 16,19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A560 ! NCI-H379
SX Female
CA Cancer cell line
//
ID NCI-H379
AC CVCL_A560
SY H379; H-379
RX PubMed=8806092;
RX PubMed=8806103;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1560 ! NCI-H378
SX Female
CA Cancer cell line
//
ID NCI-H432
AC CVCL_A563
SY H432; H-432
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A564 ! NCI-H433
SX Male
CA Cancer cell line
//
ID NCI-H433
AC CVCL_A564
SY H433; H-433
DR Cosmic; 1152469
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A563 ! NCI-H432
SX Male
CA Cancer cell line
//
ID NCI-H441
AC CVCL_1561
SY H441; H-441; NCI-H441-4; NCI-441; NCIH441
DR BTO; BTO:0001910
DR CLO; CLO_0008087
DR EFO; EFO_0002292
DR ATCC; HTB-174
DR ATCC; CRM-HTB-174
DR BCRC; 60455
DR BCRJ; 0359
DR BioSample; SAMN03473121
DR CCLE; NCIH441_LUNG
DR ChEMBL-Cells; CHEMBL3308121
DR ChEMBL-Targets; CHEMBL1075542
DR Cosmic; 687824
DR Cosmic; 722048
DR Cosmic; 801590
DR Cosmic; 844831
DR Cosmic; 876144
DR Cosmic; 897730
DR Cosmic; 903574
DR Cosmic; 908460
DR Cosmic; 914949
DR Cosmic; 917992
DR Cosmic; 1006533
DR Cosmic; 1028948
DR Cosmic; 1052332
DR Cosmic; 1146916
DR Cosmic; 1219076
DR Cosmic; 1239882
DR Cosmic; 1802306
DR Cosmic; 1870274
DR Cosmic; 1945871
DR Cosmic; 1995577
DR Cosmic; 2042863
DR Cosmic; 2125252
DR Cosmic-CLP; 908460
DR GDSC; 908460
DR GEO; GSM206492
DR GEO; GSM253415
DR GEO; GSM353231
DR GEO; GSM385521
DR GEO; GSM385532
DR GEO; GSM434308
DR GEO; GSM784265
DR GEO; GSM794287
DR GEO; GSM827516
DR GEO; GSM844650
DR GEO; GSM887428
DR GEO; GSM888508
DR GEO; GSM1670243
DR IGRhCellID; NCIH441
DR IZSLER; BS TCL 215
DR PRIDE; PXD002556
RX PubMed=2386953;
RX PubMed=8806092;
RX PubMed=11005564;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=24135919;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=26361996;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-294.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC Doubling time: 80 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9
ST D16S539: 9,13
ST D18S51: 18,19
ST D21S11: 32.2
ST D3S1358: 18
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 8,14
ST FGA: 24,25
ST Penta D: 10,12
ST Penta E: 12
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 17
DI NCIt; C5650; Papillary lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H441/CMV-Luc
AC CVCL_M254
DR JCRB; JCRB1497
DR JCRB; NIHS0728
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0728; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9
ST D16S539: 9,13
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 17,18
DI NCIt; C5650; Papillary lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1561 ! NCI-H441
SX Male
CA Cancer cell line
//
ID NCI-H446
AC CVCL_1562
SY H446; H-446; NCI-446; NCIH446
DR CLO; CLO_0008088
DR EFO; EFO_0002293
DR ATCC; HTB-171
DR BioSample; SAMN03473283
DR CCLE; NCIH446_LUNG
DR CCRID; 3111C0001CCC000082
DR CCRID; 3131C0001000700038
DR ChEMBL-Cells; CHEMBL3307760
DR ChEMBL-Targets; CHEMBL612440
DR Cosmic; 688023
DR Cosmic; 755465
DR Cosmic; 801352
DR Cosmic; 844554
DR Cosmic; 877357
DR Cosmic; 897516
DR Cosmic; 929976
DR Cosmic; 932947
DR Cosmic; 1006526
DR Cosmic; 1021863
DR Cosmic; 1152471
DR Cosmic; 1219102
DR Cosmic; 1239939
DR Cosmic; 1434963
DR Cosmic; 1995578
DR Cosmic; 2125198
DR Cosmic-CLP; 688023
DR GDSC; 688023
DR GEO; GSM169448
DR GEO; GSM380477
DR GEO; GSM784254
DR GEO; GSM845547
DR GEO; GSM887429
DR GEO; GSM888509
DR GEO; GSM1670244
DR GEO; GSM1682798
DR IGRhCellID; NCIH446
DR KCB; KCB 200688YJ
RX PubMed=1563005;
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: MYC genetic alteration cell panel (ATCC TCP-1035).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 13,14
ST D13S317: 8
ST D16S539: 12
ST D18S51: 12,13
ST D21S11: 28
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 13,15
ST FGA: 22
ST Penta D: 12,13
ST Penta E: 9,10
ST TH01: 8,9.3
ST TPOX: 9,11
ST vWA: 18,19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H449
AC CVCL_A565
SY H449; H-449
DR Cosmic; 1021864
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A566 ! NCI-H450
SX Female
CA Cancer cell line
//
ID NCI-H450
AC CVCL_A566
SY H450; H-450
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A565 ! NCI-H449
SX Female
CA Cancer cell line
//
ID NCI-H460
AC CVCL_0459
SY NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460
DR BTO; BTO:0002207
DR CLO; CLO_0003601
DR CLO; CLO_0008089
DR EFO; EFO_0003044
DR MCCL; MCC:0000356
DR CLDB; cl1548
DR ATCC; HTB-177
DR BCRC; 60373
DR BioSample; SAMN03471184
DR CCLE; NCIH460_LUNG
DR CCLV; CCLV-RIE 0962
DR CCRID; 3111C0001CCC000355
DR CCRID; 3131C0001000700039
DR CGH-DB; 199-1
DR CGH-DB; 9186-4
DR ChEMBL-Cells; CHEMBL3307677
DR ChEMBL-Targets; CHEMBL396
DR Cosmic; 722064
DR Cosmic; 724876
DR Cosmic; 755469
DR Cosmic; 844595
DR Cosmic; 875852
DR Cosmic; 877263
DR Cosmic; 877407
DR Cosmic; 897508
DR Cosmic; 905943
DR Cosmic; 911996
DR Cosmic; 931371
DR Cosmic; 947356
DR Cosmic; 980964
DR Cosmic; 1006534
DR Cosmic; 1017826
DR Cosmic; 1028956
DR Cosmic; 1032436
DR Cosmic; 1044245
DR Cosmic; 1047102
DR Cosmic; 1089231
DR Cosmic; 1092621
DR Cosmic; 1146917
DR Cosmic; 1154605
DR Cosmic; 1152502
DR Cosmic; 1188592
DR Cosmic; 1219077
DR Cosmic; 1239922
DR Cosmic; 1305349
DR Cosmic; 1312334
DR Cosmic; 1434967
DR Cosmic; 1436013
DR Cosmic; 1477420
DR Cosmic; 1802310
DR Cosmic; 1870275
DR Cosmic; 1945869
DR Cosmic; 1995579
DR Cosmic; 1998463
DR Cosmic; 2042872
DR Cosmic; 2125199
DR Cosmic; 2433756
DR Cosmic-CLP; 905943
DR DSMZ; ACC-737
DR ENCODE; ENCBS398KLJ
DR ENCODE; ENCBS446PPO
DR ENCODE; ENCBS460OUE
DR ENCODE; ENCBS514AAA
DR ENCODE; ENCBS515AAA
DR ENCODE; ENCBS641PGO
DR ENCODE; ENCBS686KKP
DR ENCODE; ENCBS798ZFS
DR ENCODE; ENCBS814QPR
DR GDSC; 905943
DR GEO; GSM50216
DR GEO; GSM50279
DR GEO; GSM206493
DR GEO; GSM253335
DR GEO; GSM385522
DR GEO; GSM385533
DR GEO; GSM434334
DR GEO; GSM513936
DR GEO; GSM514322
DR GEO; GSM750809
DR GEO; GSM784193
DR GEO; GSM794288
DR GEO; GSM799343
DR GEO; GSM799406
DR GEO; GSM827469
DR GEO; GSM844652
DR GEO; GSM844651
DR GEO; GSM847076
DR GEO; GSM887430
DR GEO; GSM888510
DR GEO; GSM1153414
DR GEO; GSM1181352
DR GEO; GSM1181361
DR GEO; GSM1374746
DR GEO; GSM1374747
DR GEO; GSM1374748
DR GEO; GSM1557134
DR IGRhCellID; NCI-H460%20GEO
DR IZSLER; BS TCL 197
DR KCB; KCB 2010102YJ
DR KCLB; 30177
DR SKY/M-FISH/CGH; 2798
RX PubMed=1563005;
RX PubMed=2041050;
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=15746151;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=19472407;
RX PubMed=19941903;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=23381221;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24135919;
RX PubMed=25120651;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=12
WW http://www.addexbio.com/productdetail?pid=39
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-613.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC Part of: JFCR39 cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 17.8 hours (DTP); ~23 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; KCLB; PubMed=19372543; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 13
ST D16S539: 9
ST D18S51: 13,15
ST D19S433: 14
ST D21S11: 30
ST D2S1338: 17,25
ST D3S1358: 15,18
ST D5S818: 9,10
ST D7S820: 9,12
ST D8S1179: 12
ST FGA: 21,23
ST Penta D: 11,13
ST Penta E: 5
ST TH01: 9.3
ST TPOX: 8 (ATCC; Cosmic-CLP; DSMZ; PubMed=19372543; PubMed=25877200)
ST TPOX: 9.3 (KCLB)
ST vWA: 17
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H460-Luc
AC CVCL_J264
DR JCRB; JCRB1407
DR JCRB; NIHS0658
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0658; true.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 13
ST D16S539: 9
ST D5S818: 9,10
ST D7S820: 9,12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0459 ! NCI-H460
SX Male
CA Cancer cell line
//
ID NCI-H460-luc2
AC CVCL_5J23
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Discontinued: PerkinElmer; Catalog number 124316.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0459 ! NCI-H460
SX Male
CA Cancer cell line
//
ID NCI-H460-Red-Fluc
AC CVCL_5J07
SY NCI-H460 Red-Fluc
WW http://www.perkinelmer.com/Catalog/Product/ID/BW124316
CC Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0459 ! NCI-H460
SX Male
CA Cancer cell line
//
ID NCI-H460M
AC CVCL_3969
SY H460M; H-460M; H460-M
DR BTO; BTO:0002836
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0459 ! NCI-H460
SX Male
CA Cancer cell line
//
ID NCI-H462
AC CVCL_A567
SY H462; H-462
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A568 ! NCI-H463
SX Male
CA Cancer cell line
//
ID NCI-H463
AC CVCL_A568
SY H463; H-463
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A567 ! NCI-H462
SX Male
CA Cancer cell line
//
ID NCI-H478
AC CVCL_A569
SY H478; H-478
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H498
AC CVCL_1563
SY H498; H-498
DR CLO; CLO_0008090
DR ATCC; CCL-254
DR BioSample; SAMN03471385
DR GEO; GSM513915
DR GEO; GSM514302
DR GEO; GSM1448214
DR KCLB; 10254
RX PubMed=3479249;
RX PubMed=8806089;
RX PubMed=8806092;
RX PubMed=8806095;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Peritoneum.
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 9,11
ST D3S1358: 15
ST D5S818: 13
ST D7S820: 8,11
ST FGA: 22,24
ST TH01: 7
ST TPOX: 8
ST vWA: 15
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H508
AC CVCL_1564
SY NCI H508; NCIH508; H508; H-508
DR CLO; CLO_0008091
DR EFO; EFO_0002294
DR ATCC; CCL-253
DR BioSample; SAMN03471384
DR CCLE; NCIH508_LARGE_INTESTINE
DR Cosmic; 685870
DR Cosmic; 908442
DR Cosmic; 1479606
DR Cosmic; 1565529
DR Cosmic; 1708418
DR Cosmic-CLP; 908442
DR GDSC; 908442
DR GEO; GSM513916
DR GEO; GSM514303
DR GEO; GSM741253
DR GEO; GSM887431
DR GEO; GSM888511
DR GEO; GSM1448142
DR GEO; GSM1670245
DR IZSLER; BS TCL 214
DR KCLB; 10253
DR SKY/M-FISH/CGH; 5012
RX PubMed=3479249;
RX PubMed=8806092;
RX PubMed=8806095;
RX PubMed=19927377;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24042735;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 32 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Abdominal wall.
ST Source(s): ATCC; Cosmic-CLP; KCLB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 12
ST D3S1358: 14,17
ST D5S818: 12
ST D7S820: 8,12
ST FGA: 24,25
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H510A
AC CVCL_1565
AS CVCL_3973
SY H510A; H-510A; NCI-H510; NCIH510; H510; H-510
DR BTO; BTO:0003023
DR CLO; CLO_0008092
DR EFO; EFO_0006693
DR ATCC; HTB-184
DR BioSample; SAMN03473048
DR CCLE; NCIH510_LUNG
DR ChEMBL-Cells; CHEMBL3308322
DR ChEMBL-Targets; CHEMBL2366332
DR Cosmic; 753605
DR Cosmic; 755466
DR Cosmic; 897519
DR Cosmic; 903575
DR Cosmic; 1006527
DR Cosmic; 1021865
DR Cosmic; 1219103
DR Cosmic; 1995580
DR Cosmic; 2125210
DR Cosmic-CLP; 753605
DR DSMZ; ACC-568
DR ECACC; 96020944
DR GDSC; 753605
DR GEO; GSM169437
DR GEO; GSM784199
DR GEO; GSM794289
DR GEO; GSM887432
DR GEO; GSM888512
DR GEO; GSM1670246
RX PubMed=1563005;
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10037197;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~1 week (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Adrenal gland.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 13
ST D18S51: 15,17
ST D21S11: 30
ST D3S1358: 16,18
ST D5S818: 9,12
ST D7S820: 10,11
ST D8S1179: 15
ST FGA: 22
ST Penta D: 9,11
ST Penta E: 12,16
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 15
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H513
AC CVCL_A570
SY H513; H-513; HUT513
DR ATCC; CRL-5830
DR BioSample; SAMN03151854
DR Cosmic; 877271
DR Cosmic; 877408
DR Cosmic; 980997
DR Cosmic; 1032388
DR Cosmic; 1152503
DR Cosmic; 1995420
DR Cosmic-CLP; 1240141
DR GDSC; 1240141
DR GEO; GSM1669835
DR KCLB; 90513
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=23830731;
RX PubMed=27397505;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a NCI-H125 derivative.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: ATCC; CRL-5830; true.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 7
ST D13S317: 11
ST D16S539: 5,12
ST D5S818: 10
ST D7S820: 10
ST TH01: 7
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C9133; Adenosquamous lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3968 ! NCI-H125
SX Male
CA Cancer cell line
//
ID NCI-H520
AC CVCL_1566
SY H520; H-520; NCI-HUT-520; NCIH520
DR BTO; BTO:0003014
DR CLO; CLO_0008093
DR EFO; EFO_0003124
DR ATCC; HTB-182
DR BCRC; 60124
DR BioSample; SAMN03471318
DR BioSample; SAMN03472735
DR CCLE; NCIH520_LUNG
DR CCRID; 3111C0001CCC000197
DR ChEMBL-Cells; CHEMBL3307864
DR ChEMBL-Targets; CHEMBL614099
DR Cosmic; 687826
DR Cosmic; 801591
DR Cosmic; 876172
DR Cosmic; 908443
DR Cosmic; 917988
DR Cosmic; 929974
DR Cosmic; 932932
DR Cosmic; 933580
DR Cosmic; 945226
DR Cosmic; 1028955
DR Cosmic; 1146918
DR Cosmic; 1219078
DR Cosmic; 1239911
DR Cosmic; 1741782
DR Cosmic; 1802297
DR Cosmic; 1995581
DR Cosmic; 2060526
DR Cosmic; 2125253
DR Cosmic-CLP; 908443
DR GDSC; 908443
DR GEO; GSM63353
DR GEO; GSM206494
DR GEO; GSM276781
DR GEO; GSM276782
DR GEO; GSM434281
DR GEO; GSM784258
DR GEO; GSM794290
DR GEO; GSM844653
DR GEO; GSM844654
DR GEO; GSM887433
DR GEO; GSM888513
DR GEO; GSM1374750
DR GEO; GSM1670247
DR IGRhCellID; NCIH520
DR KCB; KCB 2013023YJ
RX PubMed=8806092;
RX PubMed=9649128;
RX PubMed=11005564;
RX PubMed=11030152;
RX PubMed=11369051;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10,11
ST D16S539: 8,13
ST D18S51: 17
ST D21S11: 30
ST D3S1358: 16
ST D5S818: 12,13 (ATCC; Cosmic-CLP)
ST D5S818: 12 (PubMed=25877200)
ST D7S820: 8,12
ST D8S1179: 14,16,17
ST FGA: 22
ST Penta D: 13
ST Penta E: 5,14
ST TH01: 10
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H522
AC CVCL_1567
SY NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522
DR BTO; BTO:0003536
DR CLO; CLO_0008094
DR EFO; EFO_0002295
DR ATCC; CRL-5810
DR BioSample; SAMN03471314
DR CCLE; NCIH522_LUNG
DR ChEMBL-Cells; CHEMBL3308392
DR ChEMBL-Targets; CHEMBL614387
DR Cosmic; 875853
DR Cosmic; 877409
DR Cosmic; 897509
DR Cosmic; 903576
DR Cosmic; 905944
DR Cosmic; 974294
DR Cosmic; 980965
DR Cosmic; 1004696
DR Cosmic; 1032437
DR Cosmic; 1044246
DR Cosmic; 1092622
DR Cosmic; 1146919
DR Cosmic; 1154592
DR Cosmic; 1175866
DR Cosmic; 1188591
DR Cosmic; 1219062
DR Cosmic; 1239883
DR Cosmic; 1305350
DR Cosmic; 1312335
DR Cosmic; 1436012
DR Cosmic; 1802320
DR Cosmic; 1870276
DR Cosmic; 1891886
DR Cosmic; 1995582
DR Cosmic; 1998464
DR Cosmic; 2125185
DR Cosmic-CLP; 905944
DR GDSC; 905944
DR GEO; GSM50217
DR GEO; GSM50280
DR GEO; GSM206495
DR GEO; GSM353230
DR GEO; GSM434309
DR GEO; GSM513965
DR GEO; GSM514350
DR GEO; GSM750798
DR GEO; GSM784233
DR GEO; GSM794291
DR GEO; GSM799344
DR GEO; GSM799407
DR GEO; GSM827479
DR GEO; GSM847077
DR GEO; GSM887434
DR GEO; GSM888514
DR GEO; GSM1153415
DR GEO; GSM1181345
DR GEO; GSM1181346
DR GEO; GSM1374751
DR GEO; GSM1374752
DR GEO; GSM1374753
DR GEO; GSM1670248
DR IGRhCellID; NCIH522
DR KCLB; 25810
DR KCLB; 90522
DR SKY/M-FISH/CGH; 2803
RX PubMed=1563005;
RX PubMed=2041050;
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=19472407;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=7
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 38.2 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 25810; probable.
ST Source(s): ATCC; Cosmic-CLP; PubMed=19372543; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12 (Cosmic-CLP; PubMed=19372543)
ST CSF1PO: 10 (ATCC; PubMed=25877200)
ST D13S317: 10
ST D16S539: 12
ST D18S51: 14,18
ST D19S433: 16
ST D21S11: 28,31.2
ST D2S1338: 17,20
ST D3S1358: 16
ST D5S818: 10,11 (PubMed=19372543)
ST D5S818: 11 (ATCC; Cosmic-CLP; PubMed=25877200)
ST D7S820: 9,10
ST D8S1179: 12,13
ST FGA: 24
ST Penta D: 11
ST Penta E: 11
ST TH01: 7,9.3
ST TPOX: 9,10
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H524
AC CVCL_1568
SY H524; H-524; NCIH524
DR BTO; BTO:0004825
DR CLO; CLO_0008095
DR EFO; EFO_0002296
DR ATCC; CRL-5831
DR BioSample; SAMN03472976
DR CCLE; NCIH524_LUNG
DR CCRID; 3111C0001CCC000356
DR ChEMBL-Cells; CHEMBL3308296
DR ChEMBL-Targets; CHEMBL2366342
DR Cosmic; 688024
DR Cosmic; 844555
DR Cosmic; 850442
DR Cosmic; 877208
DR Cosmic; 877358
DR Cosmic; 908483
DR Cosmic; 980933
DR Cosmic; 1032399
DR Cosmic; 1152472
DR Cosmic; 1759289
DR Cosmic; 1891904
DR Cosmic; 2125200
DR Cosmic-CLP; 908483
DR GDSC; 908483
DR GEO; GSM169442
DR GEO; GSM794292
DR GEO; GSM845548
DR GEO; GSM887435
DR GEO; GSM888515
DR GEO; GSM1670249
DR IGRhCellID; NCIH524
DR KCB; KCB 2010137YJ
DR KCLB; 90524
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 100 hours (PubMed=25984343).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 90524; probable.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 12
ST D18S51: 12,13
ST D21S11: 29,30
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 11,12
ST D8S1179: 13,15
ST FGA: 25
ST Penta D: 12,13
ST Penta E: 5,15
ST TH01: 8,9.3
ST TPOX: 8,10
ST vWA: 14,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H526
AC CVCL_1569
SY H526; H-526; NCIH526
DR BTO; BTO:0005366
DR CLO; CLO_0008096
DR ATCC; CRL-5811
DR BioSample; SAMN03473065
DR CCLE; NCIH526_LUNG
DR ChEMBL-Cells; CHEMBL3308881
DR ChEMBL-Targets; CHEMBL2366102
DR Cosmic; 688025
DR Cosmic; 755467
DR Cosmic; 801615
DR Cosmic; 844556
DR Cosmic; 844820
DR Cosmic; 850439
DR Cosmic; 876164
DR Cosmic; 877209
DR Cosmic; 877359
DR Cosmic; 918012
DR Cosmic; 929975
DR Cosmic; 1021866
DR Cosmic; 1152473
DR Cosmic; 1219104
DR Cosmic; 1239940
DR Cosmic; 1891905
DR Cosmic; 1995583
DR Cosmic; 1998284
DR Cosmic; 2125214
DR Cosmic-CLP; 688025
DR GDSC; 688025
DR GEO; GSM169439
DR GEO; GSM380478
DR GEO; GSM380515
DR GEO; GSM536330
DR GEO; GSM784231
DR GEO; GSM794293
DR GEO; GSM845549
DR GEO; GSM844655
DR GEO; GSM887436
DR GEO; GSM888516
DR GEO; GSM1374754
DR GEO; GSM1670250
DR IGRhCellID; NCIH526
DR KCLB; 90526
DR TOKU-E; 2701
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10037197;
RX PubMed=11005564;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 13
ST D16S539: 9
ST D18S51: 12,15
ST D21S11: 27,32.2
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 9,12
ST D8S1179: 14
ST FGA: 22
ST Penta D: 13,14
ST Penta E: 5,13
ST TH01: 6,8
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H548
AC CVCL_1570
SY NCI H548; H548; H-548; NCIH548
DR CLO; CLO_0008097
DR ATCC; CCL-249
DR BioSample; SAMN03471379
DR GEO; GSM1374755
DR KCLB; 10249
RX PubMed=3479249;
RX PubMed=8806092;
RX PubMed=8806095;
RX PubMed=20606684;
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CCL-249; true.
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9,11
ST D16S539: 11,13
ST D3S1358: 16
ST D5S818: 12,13
ST D7S820: 9,11
ST FGA: 21,22
ST TH01: 7
ST TPOX: 10,11
ST vWA: 15,18,19 (ATCC)
ST vWA: 15,18 (KCLB)
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H568
AC CVCL_A571
SY H568; H-568
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H571
AC CVCL_A572
SY H571; H-571
RX PubMed=8806092;
RX PubMed=8806103;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H578
AC CVCL_A573
SY H578; H-578
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H580
AC CVCL_A574
SY H580; H-580
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H596
AC CVCL_1571
SY H596; H-596; NCI-HUT-596; NCIH596
DR BTO; BTO:0002209
DR CLO; CLO_0008098
DR EFO; EFO_0006694
DR ATCC; HTB-178
DR BioSample; SAMN03472805
DR CCLE; NCIH596_LUNG
DR CCRID; 3111C0001CCC000257
DR ChEMBL-Cells; CHEMBL3307791
DR ChEMBL-Targets; CHEMBL612256
DR Cosmic; 687828
DR Cosmic; 801586
DR Cosmic; 844832
DR Cosmic; 876226
DR Cosmic; 897514
DR Cosmic; 908459
DR Cosmic; 918001
DR Cosmic; 929973
DR Cosmic; 934548
DR Cosmic; 1067762
DR Cosmic; 1146920
DR Cosmic; 1188588
DR Cosmic; 1219079
DR Cosmic; 1239917
DR Cosmic; 1694668
DR Cosmic; 1802293
DR Cosmic; 1995584
DR Cosmic; 2125254
DR Cosmic-CLP; 908459
DR GDSC; 908459
DR GEO; GSM206496
DR GEO; GSM434310
DR GEO; GSM784243
DR GEO; GSM794294
DR GEO; GSM844656
DR GEO; GSM887437
DR GEO; GSM888517
DR GEO; GSM1374756
DR GEO; GSM1374757
DR GEO; GSM1670251
DR IGRhCellID; NCIH596
DR KCLB; 90596
DR PRIDE; PXD002556
RX PubMed=1563005;
RX PubMed=8806092;
RX PubMed=8806101;
RX PubMed=11005564;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=26361996;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC Part of: MD Anderson Cell Lines Project.
CC Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 11
ST D16S539: 11
ST D18S51: 18
ST D21S11: 29
ST D3S1358: 14
ST D5S818: 11,13
ST D7S820: 11
ST D8S1179: 13,14
ST FGA: 23,25
ST Penta D: 13
ST Penta E: 12,15
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C9133; Adenosquamous lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H60
AC CVCL_A592
SY H60; H-60
DR ATCC; CRL-5821
DR BioSample; SAMN03151862
DR Cosmic; 1021848
DR GEO; GSM1682797
RX PubMed=1563005;
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=6108156;
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
WW http://www.atcc.org/support/faqs/d296a/NCIH60%20ATCC%20CRL5821-1064.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a NCI-N417 derivative.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-5821; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10
ST D16S539: 9
ST D5S818: 13
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1602 ! NCI-N417
SX Female
CA Cancer cell line
//
ID NCI-H606
AC CVCL_A575
SY H606; H-606
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H615
AC CVCL_A576
SY H615; H-615
RX PubMed=8806092;
RX PubMed=8806103;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H618
AC CVCL_A577
SY H618; H-618
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H620
AC CVCL_A578
SY H620; H-620
DR Cosmic; 1021868
DR Cosmic; 1998276
DR GEO; GSM536332
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H630
AC CVCL_1572
SY H630; H-630
DR CLO; CLO_0008099
DR EFO; EFO_0002297
DR ATCC; CRL-5833
DR BioSample; SAMN03151846
DR BioSample; SAMN03481113
DR ChEMBL-Cells; CHEMBL3307966
DR ChEMBL-Targets; CHEMBL612540
DR Cosmic; 687535
DR Cosmic; 908482
DR Cosmic; 1187327
DR Cosmic-CLP; 908482
DR GDSC; 908482
DR GEO; GSM452725
DR GEO; GSM452756
DR GEO; GSM453572
DR GEO; GSM454623
DR GEO; GSM454643
DR GEO; GSM454644
DR GEO; GSM454645
DR GEO; GSM1448143
DR GEO; GSM1670252
DR IGRhCellID; NCIH630
DR IZSLER; BS TCL 191
DR KCLB; 90630
RX PubMed=3479249;
RX PubMed=8806092;
RX PubMed=8806095;
RX PubMed=27397505;
RX PubMed=25926053;
WW http://www.atcc.org/support/faqs/8fa42/NCIH630%20ATCC%20CRL5833-1065.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. The contaminant is not known. Seems to be a mixture of cell lines.
CC Microsatellite instability: Instable (MSI-high) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-5833; true.
CC Discontinued: KCLB; 90630; probable.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12,13,14 (ATCC)
ST D13S317: 11,12,13 (Cosmic-CLP)
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 8,11,12
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 15,16,17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Undefined cell line type
//
ID NCI-H64
AC CVCL_1573
SY H64; H-64
DR ATCC; CRL-5976
DR BioSample; SAMN03472629
DR ChEMBL-Cells; CHEMBL3308273
DR ChEMBL-Targets; CHEMBL2366319
DR Cosmic; 688026
DR Cosmic; 844544
DR Cosmic; 953985
DR Cosmic; 1995585
DR Cosmic-CLP; 688026
DR GDSC; 688026
DR GEO; GSM1670253
RX PubMed=2985257;
RX PubMed=6108156;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 6
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H640
AC CVCL_A579
SY H640; H-640
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H647
AC CVCL_1574
SY H647; H-647; H647ell; NCIH647
DR BTO; BTO:0005294
DR CLO; CLO_0008100
DR ATCC; CRL-5834
DR BioSample; SAMN03471319
DR CCLE; NCIH647_LUNG
DR ChEMBL-Cells; CHEMBL3308691
DR ChEMBL-Targets; CHEMBL614999
DR Cosmic; 722060
DR Cosmic; 903577
DR Cosmic; 931370
DR Cosmic; 980966
DR Cosmic; 1032438
DR Cosmic; 1146921
DR Cosmic; 1891887
DR Cosmic-CLP; 1240191
DR GDSC; 1240191
DR GEO; GSM206497
DR GEO; GSM434311
DR GEO; GSM513970
DR GEO; GSM514351
DR GEO; GSM784213
DR GEO; GSM794295
DR GEO; GSM827587
DR GEO; GSM844657
DR GEO; GSM844658
DR GEO; GSM887438
DR GEO; GSM888518
DR GEO; GSM1374758
DR GEO; GSM1670254
DR IGRhCellID; H647GEO
DR KCLB; 90647
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 90647; probable.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 9,11
ST D16S539: 9
ST D18S51: 12,15
ST D21S11: 28,32.2
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 11,13
ST FGA: 22,24
ST Penta D: 12,13
ST Penta E: 7
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 17
DI NCIt; C9133; Adenosquamous lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H650
AC CVCL_1575
SY H650; H-650
DR BTO; BTO:0004079
DR CLO; CLO_0008101
DR EFO; EFO_0002298
DR ATCC; CRL-5835
DR BioSample; SAMN03471315
DR CCLE; NCIH650_LUNG
DR ChEMBL-Cells; CHEMBL3308461
DR ChEMBL-Targets; CHEMBL1075543
DR Cosmic; 722066
DR Cosmic; 1609512
DR Cosmic; 1870277
DR Cosmic; 1995586
DR Cosmic-CLP; 722066
DR GDSC; 722066
DR GEO; GSM206498
DR GEO; GSM794296
DR GEO; GSM827481
DR GEO; GSM887439
DR GEO; GSM888519
DR GEO; GSM1670255
DR IGRhCellID; NCIH650
DR KCLB; 90650
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,12
ST D16S539: 8,11
ST D18S51: 14,20
ST D21S11: 31
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 12,14
ST FGA: 20,22
ST Penta D: 12
ST Penta E: 12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H650-Luc
AC CVCL_4Y16
DR JCRB; NIHS0729
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1575 ! NCI-H650
SX Male
CA Cancer cell line
//
ID NCI-H660
AC CVCL_1576
SY H660; H-660; NCIH660; NCI660
DR BTO; BTO:0001970
DR CLO; CLO_0008102
DR ATCC; CRL-5813
DR BioSample; SAMN03473052
DR CCLE; NCIH660_PROSTATE
DR Cosmic; 877360
DR Cosmic; 1021869
DR Cosmic; 1043331
DR Cosmic; 1075272
DR Cosmic; 1689713
DR Cosmic-CLP; 1330975
DR GEO; GSM482672
DR GEO; GSM648822
DR GEO; GSM887440
DR GEO; GSM888520
DR GEO; GSM1670256
DR IGRhCellID; NCIH660
RX PubMed=1563005;
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=14518029;
RX PubMed=22460905;
RX PubMed=23671654;
RX PubMed=25984343;
RX PubMed=27397505;
WW http://capcelllines.ca/details.asp?id=157
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 100 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 11
ST D18S51: 15,16
ST D21S11: 28,31
ST D3S1358: 14,18
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 9,10
ST FGA: 23,24
ST Penta D: 9,12
ST Penta E: 12
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H661
AC CVCL_1577
SY H661; H-661; NCIH661
DR BTO; BTO:0003013
DR CLO; CLO_0008103
DR EFO; EFO_0002299
DR ATCC; HTB-183
DR BCRC; 60125
DR BioSample; SAMN03471326
DR CCLE; NCIH661_LUNG
DR CCRID; 3111C0001CCC000357
DR CCRID; 3131C0001000700121
DR ChEMBL-Cells; CHEMBL3308139
DR ChEMBL-Targets; CHEMBL1075544
DR Cosmic; 687829
DR Cosmic; 877410
DR Cosmic; 903578
DR Cosmic; 909909
DR Cosmic; 923400
DR Cosmic; 930610
DR Cosmic; 933579
DR Cosmic; 961835
DR Cosmic; 980967
DR Cosmic; 1006540
DR Cosmic; 1032439
DR Cosmic; 1146922
DR Cosmic; 1152504
DR Cosmic; 1219063
DR Cosmic; 1239923
DR Cosmic; 1995587
DR Cosmic; 2125186
DR Cosmic-CLP; 687829
DR GDSC; 687829
DR GEO; GSM185870
DR GEO; GSM206499
DR GEO; GSM253359
DR GEO; GSM434273
DR GEO; GSM784198
DR GEO; GSM794297
DR GEO; GSM827517
DR GEO; GSM887441
DR GEO; GSM888521
DR GEO; GSM1670257
DR IGRhCellID; NCIH661
DR IZSLER; BS TCL 218
DR KCB; KCB 200823YJ
RX PubMed=8806092;
RX PubMed=9649128;
RX PubMed=11030152;
RX PubMed=11369051;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 61 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12
ST D18S51: 11
ST D21S11: 31,33.2
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 10
ST FGA: 20
ST Penta D: 11,13
ST Penta E: 12,13
ST TH01: 8
ST TPOX: 8
ST vWA: 17
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H676B
AC CVCL_1578
SY H676B; H-676B; NCI-H676; H676; H-676
DR CLO; CLO_0008104
DR ATCC; HTB-179
DR BioSample; SAMN03472732
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=11030152;
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 9
ST D13S317: 10
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 12
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 16,19
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H678
AC CVCL_A580
SY H678; H-678
DR Cosmic; 1998277
DR GEO; GSM536333
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H679
AC CVCL_A581
SY H679; H-679
DR ATCC; CRL-5977
RX PubMed=1563005;
RX PubMed=8806092;
RX PubMed=11030152;
CC Discontinued: ATCC; CRL-5977; true.
DI NCIt; C4038; Lung carcinoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H684
AC CVCL_9980
SY H684; H-684
DR CCLE; NCIH684_LIVER
DR GEO; GSM1448215
DR KCLB; 90684
RX PubMed=3479249;
RX PubMed=8806092;
RX PubMed=25926053;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Liver.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8,12
ST D3S1358: 17,18
ST D5S818: 11
ST D7S820: 10,11
ST FGA: 23
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H689
AC CVCL_A582
SY H689; H-689
DR KCLB; 90689
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Discontinued: KCLB; 90689; probable.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H69
AC CVCL_1579
SY NCI-H-69; NCI H69; H69; H-69; NCIH69; NCI-HUT-69; H69/P; NCI-H69C; H69C; H69c
DR BTO; BTO:0003022
DR CLO; CLO_0003609
DR CLO; CLO_0008105
DR EFO; EFO_0002300
DR CLDB; cl1552
DR ATCC; HTB-119
DR BioSample; SAMN03473085
DR CCLE; NCIH69_LUNG
DR CCRID; 3111C0001CCC000358
DR ChEMBL-Cells; CHEMBL3307712
DR ChEMBL-Targets; CHEMBL614805
DR CLS; 300185/p530_NCI-H69
DR Cosmic; 688027
DR Cosmic; 713879
DR Cosmic; 755459
DR Cosmic; 801610
DR Cosmic; 808518
DR Cosmic; 844545
DR Cosmic; 844817
DR Cosmic; 876167
DR Cosmic; 877351
DR Cosmic; 918010
DR Cosmic; 929160
DR Cosmic; 1006522
DR Cosmic; 1021849
DR Cosmic; 1152461
DR Cosmic; 1175859
DR Cosmic; 1212189
DR Cosmic; 1219096
DR Cosmic; 1239934
DR Cosmic; 1434964
DR Cosmic; 1571755
DR Cosmic; 1609516
DR Cosmic; 1995588
DR Cosmic; 1998272
DR Cosmic; 2125215
DR Cosmic; 2239080
DR Cosmic-CLP; 688027
DR ECACC; 91091802
DR GDSC; 688027
DR GEO; GSM169443
DR GEO; GSM380498
DR GEO; GSM536334
DR GEO; GSM784197
DR GEO; GSM794269
DR GEO; GSM827305
DR GEO; GSM845550
DR GEO; GSM844659
DR GEO; GSM887442
DR GEO; GSM888522
DR GEO; GSM1670258
DR IGRhCellID; NCIH69
DR IZSLER; BS TCL 172
DR KCLB; 30119
RX PubMed=2574988;
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=3034934;
RX PubMed=6108156;
RX PubMed=7736387;
RX PubMed=8626706;
RX PubMed=8712684;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=9212023;
RX PubMed=9559344;
RX PubMed=9744504;
RX PubMed=9815546;
RX PubMed=10037197;
RX PubMed=11005564;
RX PubMed=11030152;
RX PubMed=11414198;
RX PubMed=12569360;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=25877200
ST Amelogenin: X,Y (ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200)
ST Amelogenin: X (CLS)
ST CSF1PO: 10,12 (ATCC; CLS; ECACC; KCLB)
ST CSF1PO: 10,13 (Cosmic-CLP; PubMed=25877200)
ST D13S317: 12
ST D16S539: 11
ST D18S51: 12 (CLS)
ST D18S51: 12,15 (PubMed=25877200)
ST D21S11: 30,31.2
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 9
ST D8S1179: 13
ST FGA: 24
ST Penta D: 9,11
ST Penta E: 12
ST TH01: 8,9
ST TPOX: 10
ST vWA: 17 (Cosmic-CLP; PubMed=25877200)
ST vWA: 16,17 (ATCC; CLS; ECACC; KCLB)
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H69/CPR
AC CVCL_2137
SY H69/CPR
DR ECACC; 96042328
RX PubMed=1327513;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1579 ! NCI-H69
SX Male
CA Cancer cell line
//
ID NCI-H69/LX10
AC CVCL_2138
SY H69/LX10
DR ECACC; 96042331
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1579 ! NCI-H69
SX Male
CA Cancer cell line
//
ID NCI-H69/LX20
AC CVCL_2139
SY H69/LX20
DR CLO; CLO_0008106
DR ECACC; 96042332
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1579 ! NCI-H69
SX Male
CA Cancer cell line
//
ID NCI-H69/LX4
AC CVCL_2140
SY NCI H69-LX4; H69/LX4
DR ECACC; 96042329
RX PubMed=3011054;
RX PubMed=3034934;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 11
ST D5S818: 11,13
ST D7S820: 9
ST TH01: 8,9
ST TPOX: 10
ST vWA: 16,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1579 ! NCI-H69
SX Male
CA Cancer cell line
//
ID NCI-H69VCR/R
AC CVCL_3058
DR ECACC; 96042330
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11
ST D5S818: 11
ST D7S820: 9
ST TH01: 8,9
ST TPOX: 10
ST vWA: 16,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1579 ! NCI-H69
SX Male
CA Cancer cell line
//
ID NCI-H711
AC CVCL_1580
SY H711; H-711
DR CLO; CLO_0008107
DR ATCC; CRL-5836
DR BioSample; SAMN03471749
DR Cosmic; 844557
DR Cosmic; 877211
DR Cosmic; 877361
DR Cosmic; 910709
DR Cosmic; 1032400
DR Cosmic; 1891906
DR Cosmic; 2125255
DR GEO; GSM169446
DR GEO; GSM827535
RX PubMed=8806092;
RX PubMed=8806103;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 9,13
ST TH01: 9,9.3
ST TPOX: 11
ST vWA: 17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H716
AC CVCL_1581
SY NCI H716; H716; H-716; NCIH716
DR BTO; BTO:0004747
DR CLO; CLO_0008108
DR EFO; EFO_0002301
DR CLDB; cl3658
DR ATCC; CCL-251
DR BCRC; 60517
DR BioSample; SAMN03473254
DR CCLE; NCIH716_LARGE_INTESTINE
DR CCRID; 3111C0001CCC000359
DR CCRID; 3131C0001001200002
DR ChEMBL-Cells; CHEMBL3308297
DR ChEMBL-Targets; CHEMBL2366106
DR Cosmic; 687536
DR Cosmic; 908458
DR Cosmic; 1995589
DR Cosmic; 2302001
DR Cosmic-CLP; 908458
DR GDSC; 908458
DR GEO; GSM513917
DR GEO; GSM514304
DR GEO; GSM887443
DR GEO; GSM888523
DR GEO; GSM1346850
DR GEO; GSM1374759
DR GEO; GSM1448144
DR GEO; GSM1670259
DR IGRhCellID; NCIH716
DR KCLB; 10251
DR SKY/M-FISH/CGH; 5013
RX PubMed=1359704;
RX PubMed=3479249;
RX PubMed=8806089;
RX PubMed=8806092;
RX PubMed=8806095;
RX PubMed=19927377;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 50 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,11
ST D16S539: 11,12
ST D18S51: 15,16
ST D21S11: 32.2
ST D3S1358: 16,18
ST D5S818: 11 (ATCC; Cosmic-CLP; PubMed=25877200)
ST D5S818: 12 (KCLB)
ST D7S820: 10,11
ST D8S1179: 15
ST FGA: 20,22
ST Penta D: 9
ST Penta E: 7,12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
- 公告/新闻
免费订购电话: 400-800-2947